Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,7.981018168830227e-56,41.33162047129658,5243.647593990604,"['RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPLP0', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPS6KA2', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPS11', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPS6', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL10', 'RPL11', 'RPS15A', 'RPL14', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPL27A', 'RPS20', 'FAU', 'RPS21', 'RPS23']",3.8229077028696786e-53,0,0,67
2,Nuclear Receptors Meta-Pathway WP2882,8.676228421829308e-06,2.450943888647238,28.565563861575345,"['MGST1', 'IRS2', 'DBI', 'SLC5A3', 'CYP3A5', 'AKAP13', 'RGS2', 'FTH1', 'DNER', 'CCL2', 'HES1', 'JUNB', 'CBR3', 'EGR1', 'SREBF1', 'NQO1', 'HSP90AA1', 'GPX2', 'GADD45B', 'GPX3', 'PTGES3', 'HGF', 'SLC39A11', 'NRG1', 'SLC39A14', 'NFKB2', 'SLC2A9', 'SCD', 'FASN', 'PMP2', 'ANGPTL4', 'GCLM', 'EPHA2', 'HSPA1A', 'FKBP5', 'FTL']",0.0020081132277920623,0,0,36
3,Vitamin D Receptor Pathway WP2877,1.2576909568635047e-05,3.6540359763621013,41.23085573347316,"['CDKN1A', 'SERPINB1', 'STEAP4', 'GADD45A', 'HILPDA', 'NFATC2', 'TNFRSF11B', 'ATP2C2', 'CYP3A5', 'CEACAM1', 'BCL6', 'ID1', 'DNER', 'S100A6', 'TIMP2', 'CD9', 'PRKCQ', 'JUNB', 'HLA-DRB1']",0.0020081132277920623,0,0,19
4,Type II interferon signaling (IFNG) WP619,3.410112742923173e-05,7.679319747416763,78.99086605788186,"['SOCS3', 'CIITA', 'STAT1', 'HLA-B', 'TAP1', 'GBP1', 'IRF9', 'ICAM1', 'PSMB9']",0.0040836100096505,0,0,9
5,Complement and Coagulation Cascades WP558,5.190155586761258e-05,7.130197228144989,70.34767944791872,"['C1QB', 'CPB2', 'C1S', 'C1R', 'PROS1', 'CFI', 'SERPING1', 'F3', 'KLKB1']",0.0049721690521172856,0,0,9
6,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.00013217987121748242,4.012796504369538,35.83967762853606,"['SREBF1', 'CDKN1A', 'CEBPB', 'NOTCH1', 'MAOB', 'CEBPD', 'WNT7B', 'HMGA2', 'TNFRSF11B', 'HES1', 'JUNB', 'EMD', 'HES5']",0.010552359718862345,0,0,13
7,Allograft Rejection WP2328,0.00024009113621497626,4.823204644176511,40.198960388488494,"['C1QB', 'COL5A1', 'STAT1', 'HLA-B', 'HLA-DPB1', 'HLA-C', 'FAS', 'HLA-DRB1', 'HLA-E', 'VEGFA']",0.016429093463853375,0,0,10
8,IL1 and megakaryocytes in obesity WP2865,0.0003376684347071007,9.485980066445183,75.82567042699054,"['IL1R1', 'IL18', 'TIMP2', 'CCL2', 'MYD88', 'ICAM1']",0.019757343391461946,0,0,6
9,Spinal Cord Injury WP2431,0.00037122357102955644,3.016153417681229,23.823709276703024,"['C1QB', 'EGR1', 'ANXA1', 'IL1R1', 'GADD45A', 'BDNF', 'PLA2G5', 'TACR1', 'ICAM1', 'GFAP', 'LGALS3', 'ZFP36', 'GAP43', 'COL4A1', 'CCL2', 'SLIT3']",0.019757343391461946,0,0,16
10,IL-18 signaling pathway WP4754,0.0005064970626312256,2.117218370237829,16.06543612683753,"['CEBPB', 'NRN1', 'TSHZ1', 'RGS16', 'HSPB1', 'TNFRSF11B', 'ICAM1', 'SOCS3', 'TMSB4X', 'NFKBIZ', 'CCL2', 'RPS11', 'TICAM2', 'FN1', 'IL18', 'TACR1', 'KLF2', 'VEGFA', 'NFKB2', 'TNFRSF1A', 'ACTA2', 'CCNA2', 'KITLG', 'FAS', 'CYCS', 'KIFC3', 'PTPN7', 'MYD88', 'ARF6']",0.024261209300035703,0,0,29
11,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.0006996026450781388,11.058550185873607,80.34034535907892,"['CDKN1A', 'GALNT3', 'FAM20C', 'FGFR3', 'NFKB2']",0.030464515181129862,0,0,5
12,Hematopoietic Stem Cell Differentiation WP2849,0.0009014777980232718,4.923268095681888,34.51937187736889,"['HES6', 'CIITA', 'KITLG', 'NOTCH1', 'PIM1', 'CXCR4', 'NFATC2', 'RUNX1']",0.03321598963485748,0,0,8
13,Vitamin A and carotenoid metabolism WP716,0.0009014777980232718,4.923268095681888,34.51937187736889,"['RBP4', 'RBP2', 'RBP1', 'BCO2', 'BCO1', 'RXRG', 'RLBP1', 'RPE65']",0.03321598963485748,0,0,8
14,Complement system WP2806,0.0010418724988221339,3.8233684278309026,26.25406049718714,"['RPS19', 'C1S', 'C1R', 'PROS1', 'CFI', 'F11', 'SERPING1', 'ADM', 'KLKB1', 'ICAM1']",0.03560237026603434,0,0,10
15,Differentiation Pathway WP2848,0.0011148967724227874,5.535381750465549,37.63502431527291,"['NT5E', 'KITLG', 'NOTCH1', 'EGF', 'HGF', 'WNT7B', 'VEGFA']",0.03560237026603434,0,0,7
16,Gene regulatory network modelling somitogenesis  WP2854,0.0013619766001505818,14.73351903435469,97.22381431874224,"['LFNG', 'NOTCH1', 'HES1', 'TBX6']",0.03921149878147714,0,0,4
17,NRF2 pathway WP2884,0.0013916398314929256,2.5199624060150376,16.574479414694984,"['EGR1', 'NQO1', 'HSP90AA1', 'GPX2', 'GPX3', 'HGF', 'SLC39A11', 'NRG1', 'SLC5A3', 'SLC39A14', 'SLC2A9', 'FTH1', 'GCLM', 'FTL', 'EPHA2', 'CBR3', 'HSPA1A']",0.03921149878147714,0,0,17
18,Globo Sphingolipid Metabolism WP1424,0.0018216050182853808,6.034503171247358,38.06587102083884,"['ST6GAL1', 'ST6GAL2', 'ST8SIA1', 'ST6GALNAC3', 'A4GALT', 'ST6GALNAC5']",0.04847493354214986,0,0,6
19,Glucocorticoid Receptor Pathway WP2880,0.0019302059381486431,3.2101819970486964,20.064050240507935,"['AKAP13', 'RGS2', 'HSP90AA1', 'MGAM', 'GADD45B', 'PTGES3', 'DNER', 'CCL2', 'PMP2', 'ANGPTL4', 'NFKB2']",0.048661507598589476,0,0,11
20,VEGFA-VEGFR2 Signaling Pathway WP3888,0.0022983252513794953,1.6297495074584858,9.901664667633309,"['SHC1', 'HSPB1', 'NRARP', 'PLA2G5', 'RPL10A', 'NDRG1', 'APOLD1', 'RPL7', 'ICAM1', 'ACTG1', 'TUBA1C', 'LDHA', 'RPL18A', 'ADAMTS1', 'TMSB4X', 'RPLP2', 'CCL2', 'RPS11', 'TMSB10', 'ADAMTS9', 'MAP2K6', 'EGR1', 'HSP90AA1', 'ANXA1', 'EGR3', 'STAT1', 'RPS6', 'FN1', 'NFATC2', 'NFATC1', 'BMX', 'SOD2', 'F3', 'RAB11A', 'VEGFA', 'P4HA2', 'TXNIP', 'PTPN9', 'FAS', 'CYCS', 'MYH9', 'RPL27', 'RPL26', 'DSC1', 'ARF6', 'HSPA1A', 'EPHA2']",0.05504488977053891,0,0,47
21,Genotoxicity pathway WP4286,0.0033115325668892676,3.1663331999466453,18.08085237800326,"['ACTA2', 'ITPKC', 'PLK3', 'CDKN1A', 'RPS27', 'DAAM1', 'CEBPD', 'GADD45A', 'ID2', 'TRIM22']",0.07553448093047425,0,0,10
22,Adipogenesis WP236,0.004018254812897484,2.3075666117919638,12.73063177061593,"['WWTR1', 'SREBF1', 'CDKN1A', 'CEBPB', 'GADD45B', 'CEBPD', 'GADD45A', 'STAT1', 'IRS2', 'SOCS3', 'KLF6', 'SCD', 'NAMPT', 'PNPLA3', 'FAS', 'RXRG']",0.08200779785583708,0,0,16
23,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.0041253972790123595,2.174076649351712,11.93696993188511,"['CHRNB2', 'EGR1', 'SNAP25', 'CEBPB', 'CAV3', 'BDNF', 'CHRNA7', 'TACR1', 'GCK', 'NFKB2', 'VEGFA', 'ADCYAP1', 'SST', 'PAH', 'HES1', 'TAC1', 'HES5', 'YWHAH']",0.08200779785583708,0,0,18
24,Differentiation of white and brown adipocyte WP2895,0.004191461911309501,6.141573729863692,33.62330871232883,"['SMAD1', 'CEBPB', 'ZIC1', 'SMAD9', 'SLC7A10']",0.08200779785583708,0,0,5
25,Transcriptional cascade regulating adipogenesis WP4211,0.004280156464292123,8.838625812441968,48.2037944057474,"['SREBF1', 'CEBPB', 'CEBPD', 'KLF2']",0.08200779785583708,0,0,4
26,Striated Muscle Contraction Pathway WP383,0.004595086861033609,4.740199335548173,25.51539149560437,"['ACTA2', 'ACTN2', 'TPM2', 'TCAP', 'NEB', 'ACTG1']",0.08465563870904226,0,0,6
27,Liver X receptor pathway WP2874,0.005061890566097078,16.56122448979592,87.54288497658999,"['SREBF1', 'SCD', 'FASN']",0.08659448504144646,0,0,3
28,miR-517 relationship with ARCN1 and USP1 WP3596,0.005061890566097078,16.56122448979592,87.54288497658999,"['CDKN1A', 'ID2', 'ID1']",0.08659448504144646,0,0,3
29,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.005696613647439046,3.1147388059701493,16.096606901024977,"['SREBF1', 'SQLE', 'SCD', 'FASN', 'MSMO1', 'DHCR24', 'DHCR7', 'HSD17B7', 'TM7SF2']",0.09409234265942423,0,0,9
30,Development and heterogeneity of the ILC family WP3893,0.006667201034237823,7.364902506963788,36.902250127869,"['NFIL3', 'ZBTB16', 'ID2', 'IL18']",0.10645297651333058,0,0,4
31,Blood Clotting Cascade WP272,0.009498860518402673,11.039888682745826,51.40816274224909,"['F11', 'F3', 'KLKB1']",0.1267953700252459,0,0,3
32,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.009498860518402673,11.039888682745826,51.40816274224909,"['LFNG', 'NOTCH1', 'TBX6']",0.1267953700252459,0,0,3
33,Prostaglandin Synthesis and Regulation WP98,0.009651367465397215,3.9027086183310535,18.111126867915065,"['HSD11B1', 'EDNRA', 'ANXA1', 'ANXA2', 'S100A6', 'S100A10']",0.1267953700252459,0,0,6
34,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.009794214386083713,6.312243003050803,29.200205333840533,"['NOTCH1', 'TNC', 'CXCR4', 'VEGFA']",0.1267953700252459,0,0,4
35,Glutathione metabolism WP100,0.009794214386083713,6.312243003050803,29.200205333840533,"['GPX2', 'GPX3', 'OPLAH', 'GCLM']",0.1267953700252459,0,0,4
36,ID signaling pathway WP53,0.009794214386083713,6.312243003050803,29.200205333840533,"['SREBF1', 'ID2', 'ID1', 'ELK3']",0.1267953700252459,0,0,4
37,miR-509-3p alteration of YAP1/ECM axis WP3967,0.009794214386083713,6.312243003050803,29.200205333840533,"['EDNRA', 'COL5A1', 'PBX3', 'FN1']",0.1267953700252459,0,0,4
38,Nonalcoholic fatty liver disease WP4396,0.011140851124375246,1.900773655010943,8.548038857523501,"['COX8A', 'SREBF1', 'XBP1', 'NDUFA7', 'NDUFA4', 'COX4I1', 'NDUFB2', 'IRS2', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'TNFRSF1A', 'SOCS3', 'UQCRQ', 'CYCS', 'CCL2', 'FAS']",0.1350226205958154,0,0,19
39,Wnt signaling WP428,0.011160276947660922,2.1562011871290223,9.692974970964173,"['FZD5', 'WNT7B', 'FZD9', 'PRICKLE2', 'NFATC2', 'WNT7A', 'NFATC1', 'CCND3', 'CCND2', 'FRAT2', 'SFRP2', 'DAAM1', 'DAAM2', 'WIF1']",0.1350226205958154,0,0,14
40,Aryl Hydrocarbon Receptor Pathway WP2873,0.01198162317107706,3.685581395348837,16.306417056551734,"['NQO1', 'HSP90AA1', 'PTGES3', 'MGST1', 'HES1', 'JUNB']",0.1350226205958154,0,0,6
41,Folate Metabolism WP176,0.012121028571231863,3.2262569832402233,14.236870164691629,"['SERPINA3', 'GPX2', 'GPX3', 'CCL2', 'SOD2', 'ICAM1', 'NFKB2']",0.1350226205958154,0,0,7
42,Mitochondrial CIV Assembly WP4922,0.012121028571231863,3.2262569832402233,14.236870164691629,"['COX8A', 'COA3', 'NDUFA4', 'COX4I1', 'COX7A2', 'COX14', 'COX5B']",0.1350226205958154,0,0,7
43,The influence of laminopathies on Wnt signaling WP4844,0.012121028571231863,3.2262569832402233,14.236870164691629,"['SREBF1', 'CEBPB', 'CEBPD', 'HMGA2', 'HES1', 'EMD', 'HES5']",0.1350226205958154,0,0,7
44,Cancer immunotherapy by PD-1 blockade WP4585,0.01373693968149422,5.5227483751160635,23.679704563350253,"['NFATC2', 'NFATC1', 'PDCD1LG2', 'HLA-DRB1']",0.13951124954073887,0,0,4
45,Overview of nanoparticle effects WP3287,0.01373693968149422,5.5227483751160635,23.679704563350253,"['CCND3', 'COL4A1', 'LAMA3', 'FN1']",0.13951124954073887,0,0,4
46,Ebola Virus Pathway on Host WP4217,0.013924802888914263,2.028668832654555,8.67070028579666,"['CAV3', 'STAT1', 'ACTN1', 'HLA-B', 'HLA-C', 'ACTG1', 'HLA-E', 'NFKB2', 'BST2', 'SOCS3', 'NEDD4', 'IRF7', 'HLA-DPB1', 'FLNA', 'HLA-DRB1']",0.13951124954073887,0,0,15
47,"GPCRs, Class A Rhodopsin-like WP455",0.014041437453644105,2.3431344356578,9.995208152163721,"['GPR27', 'OXTR', 'EDNRA', 'NPFFR1', 'HTR1E', 'P2RY14', 'GPR87', 'GPR171', 'APLNR', 'ACKR4', 'CXCR4']",0.13951124954073887,0,0,11
48,Selenium Micronutrient Network WP15,0.014155418223266854,2.621612333071485,11.161928237488654,"['SERPINA3', 'GPX2', 'SELENOM', 'GPX3', 'CCL2', 'SOD2', 'ICAM1', 'SELENOH', 'NFKB2']",0.13951124954073887,0,0,9
49,Oncostatin M Signaling Pathway WP2374,0.014271505694146567,2.4606286959228134,10.456417869721882,"['SOCS3', 'EGR1', 'CEBPB', 'SHC1', 'STAT1', 'RPS6', 'CCL2', 'OSMR', 'JUNB', 'VEGFA']",0.13951124954073887,0,0,10
50,Signal transduction through IL1R WP4496,0.014680970318040646,3.4913096695226438,14.737527409600748,"['IRAK2', 'IL1R1', 'IL1RAP', 'MAP3K14', 'MYD88', 'MAP2K6']",0.14064369564682938,0,0,6
51,Neural Crest Differentiation WP2064,0.015720585312088937,2.298730382648563,9.546131348933704,"['SMAD1', 'NOTCH1', 'ID1', 'ZIC1', 'COL11A2', 'HES1', 'TBX6', 'FGFR3', 'HES5', 'GFAP', 'NFKB2']",0.1476502032253059,0,0,11
52,Peptide GPCRs WP24,0.01717527207042885,3.946494954859267,16.039678668720917,"['OXTR', 'EDNRA', 'CXCR4', 'TAC4', 'TACR1']",0.15522557210821544,0,0,5
53,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.01717527207042885,3.946494954859267,16.039678668720917,"['IFNAR2', 'STAT1', 'IRF7', 'IRF9', 'MYD88']",0.15522557210821544,0,0,5
54,DNA damage response WP707,0.018395207624621008,2.4901119402985072,9.949653383597616,"['CDKN1A', 'CCND3', 'CCND2', 'GADD45B', 'GADD45A', 'TNFRSF10B', 'FAS', 'CYCS', 'PML']",0.16317230467024932,0,0,9
55,EV release from cardiac cells and their functional effects WP3297,0.019622847663380807,22.063021316033364,86.73107589807461,"['RGS16', 'KLF2']",0.1678454291207037,0,0,2
56,SARS-CoV-2 altering angiogenesis via NRP1 WP5065,0.019622847663380807,22.063021316033364,86.73107589807461,"['NRP1', 'VEGFA']",0.1678454291207037,0,0,2
57,Immune response to tuberculosis WP4197,0.021368674757987257,3.683085501858736,14.164517863824564,"['IFNAR2', 'STAT1', 'TAP1', 'IFI35', 'IRF9']",0.17957184577326135,0,0,5
58,Ferroptosis WP4313,0.023204737424454905,2.764432029795158,10.403660243948506,"['STEAP3', 'MAP1LC3A', 'FTH1', 'GCLM', 'CP', 'SLC39A14', 'FTL']",0.18146687655435134,0,0,7
59,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.023435631645191645,6.622820037105751,24.85873974301965,"['SMAD1', 'SST', 'SMAD9']",0.18146687655435134,0,0,3
60,Complement Activation WP545,0.023435631645191645,6.622820037105751,24.85873974301965,"['C1QB', 'C1S', 'C1R']",0.18146687655435134,0,0,3
61,miRNA regulation of DNA damage response WP1530,0.023488405733548608,2.37113539445629,8.894717742295583,"['CDKN1A', 'CCND3', 'CCND2', 'GADD45B', 'GADD45A', 'TNFRSF10B', 'FAS', 'CYCS', 'PML']",0.18146687655435134,0,0,9
62,p53 transcriptional gene network WP4963,0.023488405733548608,2.37113539445629,8.894717742295583,"['CDKN1A', 'NOTCH1', 'TRAF4', 'GADD45A', 'CCL2', 'FAS', 'IRF9', 'PML', 'ICAM1']",0.18146687655435134,0,0,9
63,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.026380039248488408,2.315797466157584,8.418265702810134,"['IFI27L2', 'STAT1', 'PLCG2', 'PLCE1', 'CCL2', 'PRKCQ', 'RXRG', 'TNFRSF1A', 'NFKB2']",0.2005720444448563,0,0,9
64,Neovascularisation processes WP4331,0.029656751456332044,2.883154701718908,10.143127013342523,"['SMAD1', 'KITLG', 'NOTCH1', 'CXCR4', 'SMAD9', 'NFKB2']",0.21950907441309345,0,0,6
65,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.03101027631203216,4.015531358149743,13.947693730366051,"['ICAM1', 'NFKB2', 'VEGFA', 'TNFRSF1A']",0.21950907441309345,0,0,4
66,Heart Development WP1591,0.031620305082470664,3.2492346380931556,11.222712820051107,"['SMAD1', 'NOTCH1', 'NFATC2', 'NFATC1', 'VEGFA']",0.21950907441309345,0,0,5
67,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.031620305082470664,3.2492346380931556,11.222712820051107,"['HSP90AA1', 'ACAP1', 'IL18', 'ERBIN', 'NOD1']",0.21950907441309345,0,0,5
68,Oxidative Stress WP408,0.031620305082470664,3.2492346380931556,11.222712820051107,"['NQO1', 'GPX3', 'MGST1', 'SOD2', 'JUNB']",0.21950907441309345,0,0,5
69,Vitamin B12 metabolism WP1533,0.031620305082470664,3.2492346380931556,11.222712820051107,"['SERPINA3', 'CCL2', 'SOD2', 'ICAM1', 'NFKB2']",0.21950907441309345,0,0,5
70,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.032899473607231604,2.2125,7.554135699225793,"['CDKN1A', 'DAAM1', 'FZD5', 'SHC1', 'FZD4', 'TMSB4X', 'FZD9', 'FN1', 'PFN2']",0.22512639796948483,0,0,9
71,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.03377465874480527,1.7870544090056286,6.054619859787431,"['NOTCH1', 'FZD5', 'SHC1', 'FZD4', 'WNT7B', 'FZD9', 'FN1', 'WNT7A', 'CLDN11', 'CLDN20', 'COL4A1', 'MMP15', 'ID2', 'ID1', 'MAP2K6']",0.22786002167270036,0,0,15
72,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.03509811311981036,2.496275605214153,8.361544505839824,"['CCNA2', 'CDKN1A', 'HSP90AA1', 'FAS', 'JUNB', 'TNFRSF1A', 'MAP2K6']",0.23070762125846028,0,0,7
73,Osteoblast differentiation WP4787,0.03516003413751065,1.925407735795339,6.445967114189508,"['HES6', 'SMAD1', 'NOTCH1', 'FZD5', 'FZD4', 'STAT1', 'WNT7B', 'FZD9', 'SMAD9', 'WNT7A', 'PRKCQ', 'FGFR3']",0.23070762125846028,0,0,12
74,miRNAs involvement in the immune response in sepsis WP4329,0.03772279572702597,3.068463444857497,10.056860422429144,"['IRF7', 'TAB2', 'MYD88', 'ICAM1', 'NFKB2']",0.24417863720601946,0,0,5
75,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.03849294830395021,2.26826295791813,7.388368056153153,"['IL1R1', 'IRAK2', 'IRF7', 'TAB2', 'IL1RAP', 'MAP3K14', 'MYD88', 'MAP2K6']",0.245841629834562,0,0,8
76,Oxidative Damage WP3941,0.03993051863097831,2.6520558139534884,8.541249063100192,"['C1QB', 'CDKN1A', 'C1S', 'C1R', 'GADD45A', 'CYCS']",0.2516673476873501,0,0,6
77,Retinoblastoma gene in cancer WP2446,0.04141380796656533,2.0115440115440117,6.405039615622091,"['CCNA2', 'BARD1', 'CDKN1A', 'CCND3', 'H2AFZ', 'PRIM1', 'RPA3', 'RBP1', 'HMGB2', 'CDC7']",0.2531518698223764,0,0,10
78,Pyrimidine metabolism WP4022,0.04166362410917076,1.9322207387627948,6.140842618479125,"['NT5C', 'POLE4', 'POLD4', 'PRIM1', 'NME2', 'NME3', 'ENPP3', 'POLR2I', 'POLR2K', 'NME1', 'POLR2L']",0.2531518698223764,0,0,11
79,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.04175156099366959,1.5079463109354414,4.789265289026931,"['CDKN1A', 'CAB39L', 'COL11A2', 'LAMA3', 'TNC', 'IRS2', 'HIF3A', 'GHR', 'GNG3', 'IFNAR2', 'SREBF1', 'HSP90AA1', 'EGF', 'HGF', 'RPS6', 'FN1', 'OSMR', 'VEGFA', 'EFNA1', 'KITLG', 'COL5A1', 'PIK3IP1', 'COL4A1', 'FGFR3', 'EPHA2']",0.2531518698223764,0,0,25
80,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.04295677756504832,2.2113699906803355,6.960421589219043,"['SOCS3', 'NQO1', 'CDKN1A', 'HSPB1', 'TNFRSF10B', 'NRG1', 'YBX3', 'CARD14']",0.2572037056707268,0,0,8
81,Lung fibrosis WP3624,0.044496796426323496,2.9067207982782235,9.046697836609388,"['CEBPB', 'EGF', 'HGF', 'CCL2', 'ATP11A']",0.26076495362088453,0,0,5
82,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.04464034696641447,2.0736940298507465,6.447357751679309,"['CCND3', 'FRAT2', 'CCND2', 'SFRP2', 'FZD5', 'WIF1', 'WNT7B', 'FZD9', 'WNT7A']",0.26076495362088453,0,0,9
83,Apoptosis Modulation by HSP70 WP384,0.047372240043653834,3.397185915291765,10.360462007512782,"['FAS', 'CYCS', 'TNFRSF1A', 'HSPA1A']",0.27338919254108657,0,0,4
84,Apoptosis Modulation and Signaling WP1772,0.04947343000024967,1.9406359034842007,5.834171600167822,"['IL1R1', 'BAG3', 'TNFRSF10B', 'FAS', 'CYCS', 'TNFRSF11B', 'MAP3K14', 'MYD88', 'TNFRSF1A', 'HSPA1A']",0.2821163448823761,0,0,10
85,Electron Transport Chain (OXPHOS system in mitochondria) WP111,0.05217766065030147,1.794554142542917,5.299499332460564,"['COX8A', 'NDUFA7', 'UQCRQ', 'NDUFA4', 'COX4I1', 'NDUFB2', 'COX7A2', 'UQCR11', 'UQCR10', 'SLC25A5', 'COX5B', 'COX7A1']",0.2908059522910594,0,0,12
86,Aryl Hydrocarbon Receptor Netpath WP2586,0.05221150709192297,2.4551937984496126,7.248842739253963,"['NQO1', 'CDKN1A', 'HSP90AA1', 'KLF6', 'PSRC1', 'VEGFA']",0.2908059522910594,0,0,6
87,FOXA2 pathway WP5066,0.057246052930298365,4.138218923933209,11.836947271270123,"['SREBF1', 'FASN', 'IRS2']",0.31160067447287404,0,0,3
88,NOTCH1 regulation of endothelial cell calcification WP3413,0.057246052930298365,4.138218923933209,11.836947271270123,"['NOTCH1', 'FGFR3', 'VEGFA']",0.31160067447287404,0,0,3
89,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.05843735860143243,7.353104726598702,20.881346005450727,"['CD247', 'HLA-DRB1']",0.314511177191979,0,0,2
90,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.05912396828251279,2.3673089700996677,6.695031198078753,"['IFITM3', 'BST2', 'IFITM2', 'RPS6KA2', 'JUNB', 'MAP2K6']",0.31467089785915137,0,0,6
91,Myometrial relaxation and contraction pathways WP289,0.06122555726948439,1.6281315528087408,4.5476817068514785,"['OXTR', 'RGS16', 'ADM', 'ADCY2', 'ACTG1', 'RGS4', 'ACTA2', 'RGS2', 'GNG3', 'GRK5', 'PLCG2', 'PRKCQ', 'CALM3', 'IGFBP6', 'YWHAH']",0.3222751860668464,0,0,15
92,IL-1 signaling pathway WP195,0.064156070050947,2.0096585613826994,5.519399765437441,"['IL1R1', 'IRAK2', 'CCL2', 'TAB2', 'IL1RAP', 'MAP3K14', 'MYD88', 'MAP2K6']",0.33402997341743057,0,0,8
93,Ovarian infertility WP34,0.06765975420624587,2.943732590529248,7.928248271097535,"['EGR1', 'CEBPB', 'CCND2', 'SYNE2']",0.34743035138448425,0,0,4
94,IL17 signaling pathway WP2112,0.06890581081738205,2.509716120310916,6.713527684181267,"['CEBPB', 'CEBPD', 'IL17RE', 'MAP3K14', 'IL17RB']",0.34743035138448425,0,0,5
95,Wnt signaling in kidney disease WP4150,0.06890581081738205,2.509716120310916,6.713527684181267,"['FZD5', 'FZD4', 'WNT7B', 'FZD9', 'WNT7A']",0.34743035138448425,0,0,5
96,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.08290663941133657,5.514365152919369,13.730990525810329,"['SOCS3', 'CHI3L1']",0.4076721326930546,0,0,2
97,PTF1A related regulatory pathway WP4147,0.08290663941133657,5.514365152919369,13.730990525810329,"['NOTCH1', 'HES1']",0.4076721326930546,0,0,2
98,IL-4 signaling pathway WP395,0.08425791469021379,1.9828821085804327,4.905398057018844,"['SOCS3', 'CEBPB', 'NFIL3', 'SHC1', 'STAT1', 'FLNA', 'IRS2']",0.4076721326930546,0,0,7
99,Interferon type I signaling pathways WP585,0.08425791469021379,1.9828821085804327,4.905398057018844,"['IFNAR2', 'SOCS3', 'STAT1', 'RPS6', 'IRS2', 'IRF9', 'MAP2K6']",0.4076721326930546,0,0,7
100,Breast cancer pathway WP4262,0.08601830737108764,1.5645678907159695,3.8381903284560464,"['CDKN1A', 'NOTCH1', 'GADD45B', 'FZD5', 'SHC1', 'GADD45A', 'EGF', 'WNT7B', 'FZD9', 'WNT7A', 'NFKB2', 'FRAT2', 'HES1', 'HES5']",0.4120276923075098,0,0,14
101,Hypertrophy Model WP516,0.08770660730358945,3.310018552875696,8.055784274237023,"['IL1R1', 'IL18', 'VEGFA']",0.4159550980041519,0,0,3
102,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.09171657318349832,2.5969741657108525,6.204306800838982,"['TICAM2', 'IRAK2', 'CCL2', 'MYD88']",0.4209122994510934,0,0,4
103,Notch Signaling WP268,0.09194868073029594,2.0706976744186045,4.94177109595701,"['LFNG', 'NUMBL', 'NOTCH1', 'DTX3L', 'HES1', 'HES5']",0.4209122994510934,0,0,6
104,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.09194868073029594,2.0706976744186045,4.94177109595701,"['IFNAR2', 'STAT1', 'CD160', 'CXCL17', 'IRF7', 'CCL2']",0.4209122994510934,0,0,6
105,RANKL/RANK signaling pathway WP2018,0.09226678797988477,1.933147113594041,4.606826881387879,"['STAT1', 'TNFRSF11B', 'NFATC1', 'TAB2', 'ICAM1', 'MAP2K6', 'NFKB2']",0.4209122994510934,0,0,7
106,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.09534522070405783,1.7449430479183032,4.101054268781382,"['CCND3', 'CCND2', 'FRAT2', 'SFRP2', 'FZD5', 'WIF1', 'WNT7B', 'FZD9', 'WNT7A']",0.4308524595966387,0,0,9
107,Wnt signaling pathway and pluripotency WP399,0.10499803239360767,1.6495951614476636,3.717880121716708,"['CCND3', 'CCND2', 'FZD5', 'FZD4', 'WNT7B', 'ESRRB', 'FZD9', 'WNT7A', 'PRKCQ', 'CD44']",0.43381124426980194,0,0,10
108,Imatinib and Chronic Myeloid Leukemia WP3640,0.10499826579122236,3.008854781582054,6.7813913437799345,"['GADD45A', 'PIM1', 'PIM2']",0.43381124426980194,0,0,3
109,Phytochemical activity on NRF2 transcriptional activation WP3,0.10499826579122236,3.008854781582054,6.7813913437799345,"['NQO1', 'CEBPB', 'GCLM']",0.43381124426980194,0,0,3
110,SARS coronavirus and innate immunity WP4912,0.10499826579122236,3.008854781582054,6.7813913437799345,"['IFNAR2', 'STAT1', 'IRF9']",0.43381124426980194,0,0,3
111,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.10499826579122236,3.008854781582054,6.7813913437799345,"['ID1', 'TNC', 'FN1']",0.43381124426980194,0,0,3
112,Toll-like Receptor Signaling related to MyD88 WP3858,0.1050713076003618,2.452491488703188,5.5257479094900095,"['TICAM2', 'IRF7', 'MYD88', 'NFKB2']",0.43381124426980194,0,0,4
113,Ectoderm Differentiation WP2858,0.10678383976719905,1.5032984231262683,3.362801418667649,"['KCNK10', 'FZD5', 'TSC22D1', 'FZD4', 'ZBTB16', 'HMGB2', 'TNFRSF11B', 'NFATC1', 'CLDN11', 'MAFB', 'PODXL', 'PIM1', 'CCL2', 'KIFC3']",0.43381124426980194,0,0,14
114,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.10982870336205038,4.41112140871177,9.743432162778893,"['DHCR24', 'DHCR7']",0.43381124426980194,0,0,2
115,Dual hijack model of Vif in HIV infection WP3300,0.10982870336205038,4.41112140871177,9.743432162778893,"['ELOB', 'RUNX1']",0.43381124426980194,0,0,2
116,Estrogen metabolism WP697,0.10982870336205038,4.41112140871177,9.743432162778893,"['NQO1', 'ARSE']",0.43381124426980194,0,0,2
117,Farnesoid X receptor pathway WP2879,0.10982870336205038,4.41112140871177,9.743432162778893,"['IRS2', 'FKBP5']",0.43381124426980194,0,0,2
118,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.10982870336205038,4.41112140871177,9.743432162778893,"['HES1', 'VEGFA']",0.43381124426980194,0,0,2
119,Platelet-mediated interactions with vascular and circulating cells WP4462,0.10982870336205038,4.41112140871177,9.743432162778893,"['CCL2', 'ICAM1']",0.43381124426980194,0,0,2
120,Type III interferon signaling WP2113,0.10982870336205038,4.41112140871177,9.743432162778893,"['STAT1', 'IRF9']",0.43381124426980194,0,0,2
121,Type 2 papillary renal cell carcinoma WP4241,0.11078050078618541,2.122891049470975,4.670794452454503,"['CDKN1A', 'EGLN3', 'COL21A1', 'ELOB', 'VEGFA']",0.43381124426980194,0,0,5
122,Endochondral Ossification with Skeletal Dysplasias WP4808,0.11139620677491782,1.948563611491108,4.276438517716737,"['GHR', 'ADAMTS1', 'STAT1', 'FGFR3', 'DDR2', 'VEGFA']",0.43381124426980194,0,0,6
123,Endochondral Ossification WP474,0.11139620677491782,1.948563611491108,4.276438517716737,"['GHR', 'ADAMTS1', 'STAT1', 'FGFR3', 'DDR2', 'VEGFA']",0.43381124426980194,0,0,6
124,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.11924994903682436,2.323217514538435,4.940400050359917,"['RAB3B', 'HSPB1', 'NDRG1', 'RAB11A']",0.4550325869854334,0,0,4
125,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.12184353564569567,1.8927308970099668,3.9842317595255348,"['EIF4A2', 'RPS6KA2', 'RPS6', 'PIM1', 'PIM2', 'MAP2K6']",0.4550325869854334,0,0,6
126,Cholesterol Biosynthesis Pathway WP197,0.12349527412965834,2.7578849721706864,5.768260904345065,"['SQLE', 'MSMO1', 'DHCR7']",0.4550325869854334,0,0,3
127,Mitochondrial complex III assembly WP4921,0.12349527412965834,2.7578849721706864,5.768260904345065,"['UQCRQ', 'UQCR11', 'UQCR10']",0.4550325869854334,0,0,3
128,NAD+ metabolism WP3644,0.12349527412965834,2.7578849721706864,5.768260904345065,"['NT5E', 'NAMPT', 'CD38']",0.4550325869854334,0,0,3
129,Overview of interferons-mediated signaling pathway WP4558,0.12349527412965834,2.7578849721706864,5.768260904345065,"['IFNAR2', 'STAT1', 'IRF9']",0.4550325869854334,0,0,3
130,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.12349527412965834,2.7578849721706864,5.768260904345065,"['SREBF1', 'SCD', 'FASN']",0.4550325869854334,0,0,3
131,MAPK Signaling Pathway WP382,0.13380313322522228,1.3355562784645414,2.686318819191755,"['PTPRR', 'IL1R1', 'GADD45A', 'BDNF', 'EGF', 'CACNA2D3', 'HSPB1', 'NFATC1', 'NFKB2', 'TNFRSF1A', 'MRAS', 'FLNA', 'FAS', 'TAB2', 'PTPN7', 'MAP3K6', 'FGFR3', 'MAP3K14', 'HSPA1B', 'HSPA1A', 'MAP2K6']",0.48332391515582,0,0,21
132,Tryptophan metabolism WP465,0.13420058604535295,2.206870937790158,4.432323039227467,"['WARS', 'MAOB', 'AADAT', 'DHCR24']",0.48332391515582,0,0,4
133,White fat cell differentiation WP4149,0.13420058604535295,2.206870937790158,4.432323039227467,"['SREBF1', 'CEBPB', 'CEBPD', 'KLF2']",0.48332391515582,0,0,4
134,Inflammatory Response Pathway WP453,0.13862641324676558,3.675625579240037,7.26293557437849,"['FN1', 'TNFRSF1A']",0.4846865105489103,0,0,2
135,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.13862641324676558,3.675625579240037,7.26293557437849,"['EGF', 'FN1']",0.4846865105489103,0,0,2
136,Nanoparticle triggered regulated necrosis WP2513,0.13862641324676558,3.675625579240037,7.26293557437849,"['TNFRSF1A', 'FTL']",0.4846865105489103,0,0,2
137,RAS and bradykinin pathways in COVID-19 WP4969,0.13862641324676558,3.675625579240037,7.26293557437849,"['SERPING1', 'KLKB1']",0.4846865105489103,0,0,2
138,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.14239208646267695,1.5779584221748402,3.075710565551153,"['MRAS', 'SHC1', 'EGF', 'HGF', 'RPS6', 'PLCG2', 'NRG1', 'FGFR3', 'VEGFA']",0.49300500676163805,0,0,9
139,miRNA targets in ECM and membrane receptors WP2911,0.1430640833817697,2.5455259026687598,4.949679949608643,"['COL5A1', 'COL4A1', 'FN1']",0.49300500676163805,0,0,3
140,Exercise-induced Circadian Regulation WP410,0.1441096500940647,1.7901194217473286,3.4677849917437116,"['CEBPB', 'RBPMS', 'PPP1R3C', 'TAB2', 'ERC2', 'ETV6']",0.49306087425040707,0,0,6
141,IL-2 signaling pathway WP49,0.14857229148194742,1.9028009229585952,3.6280393668959974,"['SOCS3', 'CCND2', 'SHC1', 'STAT1', 'RPS6']",0.5047243093606583,0,0,5
142,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.15957480014664047,11.021296296296295,20.226751370822033,['FAS'],0.5348001252047111,0,0,1
143,Calcium Regulation in the Cardiac Cell WP536,0.15965849249326447,1.408404935007711,2.584026120455854,"['RGS16', 'ATP1A4', 'ADCY2', 'ATP1B2', 'RGS4', 'RGS2', 'GNG3', 'PLN', 'GRK5', 'GJA9', 'PRKCQ', 'CALM3', 'YWHAH']",0.5348001252047111,0,0,13
144,Fas ligand pathway and stress induction of heat shock proteins WP314,0.16224175381922373,1.8392193308550187,3.3449288796424357,"['HSPB1', 'FAS', 'CYCS', 'ACTG1', 'LMNB1']",0.536642354311362,0,0,5
145,Angiogenesis WP1539,0.16356948586525855,2.3635038430956796,4.279164806717967,"['SMAD1', 'TIMP2', 'VEGFA']",0.536642354311362,0,0,3
146,Transcription factor regulation in adipogenesis WP3599,0.16356948586525855,2.3635038430956796,4.279164806717967,"['CEBPB', 'CEBPD', 'IRS2']",0.536642354311362,0,0,3
147,ESC Pluripotency Pathways WP3931,0.167781937805266,1.4726423902894492,2.628799398798355,"['SMAD1', 'FZD5', 'FZD4', 'EGF', 'WNT7B', 'FZD9', 'SMAD9', 'WNT7A', 'FGFR3', 'MAP2K6']",0.54632402391315,0,0,10
148,Dopamine metabolism WP2436,0.16880157732598375,3.150271415331656,5.604431616809005,"['NQO1', 'MAOB']",0.54632402391315,0,0,2
149,G1 to S cell cycle control WP45,0.18065504709195904,1.6554418604651162,2.832735633361702,"['CDKN1A', 'CCND3', 'CCND2', 'GADD45A', 'PRIM1', 'RPA3']",0.5807635406513314,0,0,6
150,Ebstein-Barr virus LMP1 signaling WP262,0.18487710200382404,2.205751391465677,3.7234494907463644,"['HSP90AA1', 'MAP3K14', 'NFKB2']",0.586464449402859,0,0,3
151,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.18487710200382404,2.205751391465677,3.7234494907463644,"['UGCG', 'GALNT16', 'ST6GALNAC3']",0.586464449402859,0,0,3
152,Small cell lung cancer WP4658,0.18904098079385212,1.4613147497805092,2.4342456273846738,"['CDKN1A', 'TRAF4', 'GADD45B', 'COL4A1', 'GADD45A', 'LAMA3', 'FN1', 'CYCS', 'RXRG']",0.5918341817010142,0,0,9
153,TNF-alpha signaling pathway WP231,0.18904098079385212,1.4613147497805092,2.4342456273846738,"['HSP90AA1', 'OTUD7B', 'CCL2', 'TAB2', 'PYGL', 'MAP3K14', 'TNFRSF1A', 'MAP2K6', 'NFKB2']",0.5918341817010142,0,0,9
154,Cardiac Hypertrophic Response WP2795,0.1935899160531756,1.6149290981281905,2.65173488326857,"['EGF', 'NFATC2', 'NRG1', 'MAP3K14', 'TNFRSF1A', 'MAP2K6']",0.5965158125852591,0,0,6
155,Eicosanoid Synthesis WP167,0.199925823718869,2.7562557924003706,4.437045002290414,"['PNPLA3', 'PLA2G5']",0.5965158125852591,0,0,2
156,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.199925823718869,2.7562557924003706,4.437045002290414,"['GRM3', 'GRM8']",0.5965158125852591,0,0,2
157,Iron metabolism in placenta WP2007,0.199925823718869,2.7562557924003706,4.437045002290414,"['STEAP3', 'FTH1']",0.5965158125852591,0,0,2
158,miRNAs involved in DNA damage response WP1545,0.199925823718869,2.7562557924003706,4.437045002290414,"['CDKN1A', 'CCND3']",0.5965158125852591,0,0,2
159,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.20056190178827027,1.8384401114206128,2.9536973432841878,"['IFNAR2', 'STAT1', 'IRF9', 'MYD88']",0.5965158125852591,0,0,4
160,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.2053858819978426,1.514788038120276,2.397704540846132,"['EGR1', 'CCND3', 'STAT1', 'RPS6', 'ADCY2', 'RALGDS', 'MAP2K6']",0.5965158125852591,0,0,7
161,Cardiac Progenitor Differentiation WP2406,0.2068553588485531,2.0677179962894248,3.2581766083123265,"['NOTCH1', 'CXCR4', 'NRG1']",0.5965158125852591,0,0,3
162,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.2068553588485531,2.0677179962894248,3.2581766083123265,"['LDHA', 'RPS6', 'VEGFA']",0.5965158125852591,0,0,3
163,Sleep regulation WP3591,0.2068553588485531,2.0677179962894248,3.2581766083123265,"['CHRNB2', 'OXTR', 'IL18']",0.5965158125852591,0,0,3
164,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.2068553588485531,2.0677179962894248,3.2581766083123265,"['WIF1', 'ZBTB16', 'PML']",0.5965158125852591,0,0,3
165,Metapathway biotransformation Phase I and II WP702,0.21438922301846045,1.3800186741363212,2.125176478675427,"['CYP39A1', 'HS3ST3B1', 'CHST9', 'GPX2', 'CHST6', 'HS3ST3A1', 'GPX3', 'CYP4F3', 'MGST1', 'CYP3A5']",0.5965158125852591,0,0,10
166,MECP2 and Associated Rett Syndrome WP3584,0.2176133839095449,1.4855321587165162,2.2654889203535937,"['CEBPD', 'BCL6', 'BDNF', 'SST', 'RPS6', 'TAP1', 'FKBP5']",0.5965158125852591,0,0,7
167,Toll-like Receptor Signaling Pathway WP75,0.2176133839095449,1.4855321587165162,2.2654889203535937,"['IFNAR2', 'TICAM2', 'STAT1', 'IRF7', 'TAB2', 'MYD88', 'MAP2K6']",0.5965158125852591,0,0,7
168,"GPCRs, Other WP117",0.21848345076246245,1.764753946146704,2.6842701793097055,"['EDNRA', 'GRM8', 'LGR6', 'GPR135']",0.5965158125852591,0,0,4
169,Glycogen Synthesis and Degradation WP500,0.22137362120468473,1.6222938989722282,2.446262504266388,"['HKDC1', 'PYGM', 'CALM3', 'PYGL', 'GYG2']",0.5965158125852591,0,0,5
170,Cell cycle WP179,0.22429297736418216,1.3628661341079642,2.037215223429507,"['CCNA2', 'CCND3', 'CDKN1A', 'CCND2', 'GADD45B', 'GADD45A', 'CDC7', 'ANAPC11', 'YWHAH', 'SMC1B']",0.5965158125852591,0,0,10
171,Focal Adhesion WP306,0.22553328522606386,1.2744263241448983,1.8979872255812034,"['CAV3', 'SHC1', 'EGF', 'ACTN1', 'HGF', 'LAMA3', 'FN1', 'TNC', 'MYL12A', 'VEGFA', 'ACTG1', 'CCND3', 'CCND2', 'COL4A1', 'FLNA']",0.5965158125852591,0,0,15
172,Canonical and non-canonical Notch signaling WP3845,0.2293770364285257,1.9459238240750847,2.865155241738093,"['NOTCH1', 'DNER', 'HES1']",0.5965158125852591,0,0,3
173,Benzene metabolism WP3891,0.2295508040199708,5.510185185185185,8.108958814655075,['NQO1'],0.5965158125852591,0,0,1
174,COVID-19 adverse outcome pathway WP4891,0.2295508040199708,5.510185185185185,8.108958814655075,['CCL2'],0.5965158125852591,0,0,1
175,Drug Induction of Bile Acid Pathway WP2289,0.2295508040199708,5.510185185185185,8.108958814655075,['SLC51A'],0.5965158125852591,0,0,1
176,Hfe effect on hepcidin production WP3924,0.2295508040199708,5.510185185185185,8.108958814655075,['ID1'],0.5965158125852591,0,0,1
177,Hypothetical Craniofacial Development Pathway WP3655,0.2295508040199708,5.510185185185185,8.108958814655075,['ARHGAP29'],0.5965158125852591,0,0,1
178,let-7 inhibition of ES cell reprogramming WP3299,0.2295508040199708,5.510185185185185,8.108958814655075,['EGR1'],0.5965158125852591,0,0,1
179,Macrophage markers WP4146,0.2295508040199708,5.510185185185185,8.108958814655075,['F3'],0.5965158125852591,0,0,1
180,Steroid Biosynthesis WP496,0.2295508040199708,5.510185185185185,8.108958814655075,['HSD17B7'],0.5965158125852591,0,0,1
181,GPR40 Pathway WP3958,0.23163244497047641,2.4497991967871484,3.583084763272559,"['PLCG2', 'PLCE1']",0.5965158125852591,0,0,2
182,Kynurenine Pathway and links to Cellular Senescence WP5044,0.23163244497047641,2.4497991967871484,3.583084763272559,"['CDKN1A', 'AADAT']",0.5965158125852591,0,0,2
183,Leptin Insulin Overlap WP3935,0.23163244497047641,2.4497991967871484,3.583084763272559,"['SOCS3', 'IRS2']",0.5965158125852591,0,0,2
184,Matrix Metalloproteinases WP129,0.23163244497047641,2.4497991967871484,3.583084763272559,"['MMP15', 'TIMP2']",0.5965158125852591,0,0,2
185,Nicotine Activity on Dopaminergic Neurons WP1602,0.23163244497047641,2.4497991967871484,3.583084763272559,"['CHRNB2', 'ADCY2']",0.5965158125852591,0,0,2
186,Tryptophan catabolism leading to NAD+ production WP4210,0.23163244497047641,2.4497991967871484,3.583084763272559,"['AADAT', 'NAMPT']",0.5965158125852591,0,0,2
187,Bladder cancer WP2828,0.23681120126960845,1.6967359474323263,2.4441346846804803,"['CDKN1A', 'EGF', 'FGFR3', 'VEGFA']",0.6065912588670719,0,0,4
188,PI3K-Akt signaling pathway WP4172,0.23889669812904302,1.2084905660377359,1.7302250026255623,"['IFNAR2', 'CDKN1A', 'HSP90AA1', 'BDNF', 'EGF', 'HGF', 'RPS6', 'LAMA3', 'FN1', 'TNC', 'OSMR', 'VEGFA', 'EFNA1', 'GHR', 'KITLG', 'CCND3', 'GNG3', 'CCND2', 'COL4A1', 'FGFR3', 'EPHA2']",0.6086782893819767,0,0,21
189,T-cell receptor (TCR) signaling pathway WP69,0.24280935906187917,1.4302710531760812,2.024518174033856,"['SHC1', 'NFATC2', 'FAS', 'PRKCQ', 'NFATC1', 'CD247', 'MAP3K14']",0.615373984077461,0,0,7
190,EPO Receptor Signaling WP581,0.25232044801162085,1.8376623376623376,2.5305628090684342,"['SHC1', 'STAT1', 'IRS2']",0.6189645389063658,0,0,3
191,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.25232044801162085,1.8376623376623376,2.5305628090684342,"['CDKN1A', 'STAT1', 'FGFR3']",0.6189645389063658,0,0,3
192,Unfolded protein response WP4925,0.25232044801162085,1.8376623376623376,2.5305628090684342,"['XBP1', 'TNFRSF10B', 'TXNIP']",0.6189645389063658,0,0,3
193,Regulation of toll-like receptor signaling pathway WP1449,0.252413322398768,1.3421490520371118,1.8477196443404953,"['IFNAR2', 'TICAM2', 'IRAK2', 'STAT1', 'IRF7', 'TAB2', 'MYD88', 'MAP2K6', 'NFKB2']",0.6189645389063658,0,0,9
194,One-carbon metabolism and related pathways WP3940,0.2530903956928147,1.531908302354399,2.104855118794286,"['GPX2', 'AHCYL1', 'GPX3', 'SOD2', 'GCLM']",0.6189645389063658,0,0,5
195,CAMKK2  Pathway WP4874,0.25548241636235025,1.6337563189930877,2.22942663755058,"['FIS1', 'MAP1LC3A', 'NFATC2', 'ICAM1']",0.6189645389063658,0,0,4
196,Prolactin Signaling Pathway WP2037,0.2557397579269144,1.4041476214660573,1.914688566592617,"['SOCS3', 'SHC1', 'STAT1', 'RPS6KA2', 'RPS6', 'FLNA', 'IRS2']",0.6189645389063658,0,0,7
197,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.2628129597166878,1.4387866531850353,1.9226688478862894,"['ACTN2', 'ACTN1', 'CACNA2D3', 'EMD', 'DSC2', 'ACTG1']",0.6189645389063658,0,0,6
198,Notch Signaling Pathway Netpath WP61,0.2628129597166878,1.4387866531850353,1.9226688478862894,"['HES6', 'CDKN1A', 'NUMBL', 'NOTCH1', 'HES1', 'HES5']",0.6189645389063658,0,0,6
199,BMP Signaling Pathway in Eyelid Development WP3927,0.26360911469081133,2.204633920296571,2.939411728134956,"['SMAD1', 'NOTCH1']",0.6189645389063658,0,0,2
200,Computational Model of Aerobic Glycolysis WP4629,0.26360911469081133,2.204633920296571,2.939411728134956,"['LDHA', 'PGAM2']",0.6189645389063658,0,0,2
201,Fatty acid transporters WP5061,0.26360911469081133,2.204633920296571,2.939411728134956,"['FABP5', 'DBI']",0.6189645389063658,0,0,2
202,Galanin receptor pathway WP4970,0.26360911469081133,2.204633920296571,2.939411728134956,"['CDKN1A', 'VEGFA']",0.6189645389063658,0,0,2
203,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.26360911469081133,2.204633920296571,2.939411728134956,"['CCL2', 'NFKB2']",0.6189645389063658,0,0,2
204,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.26360911469081133,2.204633920296571,2.939411728134956,"['MAP3K14', 'MAP2K6']",0.6189645389063658,0,0,2
205,Circadian rhythm related genes WP3594,0.266862566775035,1.2364086223055295,1.6333223534160028,"['CHRNB2', 'KLF10', 'EGR1', 'SREBF1', 'EGR3', 'CARTPT', 'PML', 'CIART', 'NFIL3', 'ID2', 'NOCT', 'NAMPT', 'FAS', 'RPS27A']",0.6235471682206916,0,0,14
206,Cytosolic DNA-sensing pathway WP4655,0.26935210735911547,1.4903797849894505,1.9549845285348773,"['RNF125', 'IL18', 'IRF7', 'POLR2K', 'POLR2L']",0.6263090263350306,0,0,5
207,p38 MAPK Signaling Pathway WP400,0.27443546721919926,1.5752752354423663,2.0368925321847287,"['SHC1', 'STAT1', 'HSPB1', 'MAP2K6']",0.6282008624535789,0,0,4
208,DNA Mismatch Repair WP531,0.2755703118919561,1.7407967971877747,2.2437346950571544,"['POLE4', 'POLD4', 'RPA3']",0.6282008624535789,0,0,3
209,NRF2-ARE regulation WP4357,0.2755703118919561,1.7407967971877747,2.2437346950571544,"['NQO1', 'CEBPB', 'GCLM']",0.6282008624535789,0,0,3
210,TLR4 Signaling and Tolerance WP3851,0.2755703118919561,1.7407967971877747,2.2437346950571544,"['IRF7', 'TAB2', 'MYD88']",0.6282008624535789,0,0,3
211,DNA damage response (only ATM dependent) WP710,0.2864456485716494,1.2895304322543129,1.6121792885387207,"['CCND3', 'CDKN1A', 'CCND2', 'BCL6', 'SHC1', 'WNT7B', 'WNT7A', 'SOD2', 'NFKB2']",0.6282008624535789,0,0,9
212,Hepatitis C and Hepatocellular Carcinoma WP3646,0.29361027188549094,1.5208273300675568,1.863776929888866,"['CDKN1A', 'PODXL', 'CD44', 'VEGFA']",0.6282008624535789,0,0,4
213,Cells and molecules involved in local acute inflammatory response  WP4493,0.2937053614166553,3.6731481481481483,4.500260985813421,['ICAM1'],0.6282008624535789,0,0,1
214,FTO Obesity Variant Mechanism WP3407,0.2937053614166553,3.6731481481481483,4.500260985813421,['ARID5B'],0.6282008624535789,0,0,1
215,"Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases WP4518",0.2937053614166553,3.6731481481481483,4.500260985813421,['OPLAH'],0.6282008624535789,0,0,1
216,Irinotecan pathway WP229,0.2937053614166553,3.6731481481481483,4.500260985813421,['CYP3A5'],0.6282008624535789,0,0,1
217,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.2937053614166553,3.6731481481481483,4.500260985813421,['CDKN1A'],0.6282008624535789,0,0,1
218,Tamoxifen metabolism WP691,0.2937053614166553,3.6731481481481483,4.500260985813421,['CYP3A5'],0.6282008624535789,0,0,1
219,The alternative pathway of fetal androgen synthesis WP4524,0.2937053614166553,3.6731481481481483,4.500260985813421,['HSD17B6'],0.6282008624535789,0,0,1
220,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.2955913877724352,2.004044148622462,2.4424833663701886,"['RPH3AL', 'SYTL4']",0.6282008624535789,0,0,2
221,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.2955913877724352,2.004044148622462,2.4424833663701886,"['EGF', 'HSPB1']",0.6282008624535789,0,0,2
222,Omega-9 FA synthesis WP4724,0.2955913877724352,2.004044148622462,2.4424833663701886,"['SCD', 'FASN']",0.6282008624535789,0,0,2
223,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.2955913877724352,2.004044148622462,2.4424833663701886,"['NQO1', 'FN1']",0.6282008624535789,0,0,2
224,TP53 network WP1742,0.2955913877724352,2.004044148622462,2.4424833663701886,"['CDKN1A', 'GADD45A']",0.6282008624535789,0,0,2
225,Non-small cell lung cancer WP4255,0.29562570464736015,1.3311821742759904,1.6222599809306375,"['CDKN1A', 'GADD45B', 'EGF', 'GADD45A', 'PLCG2', 'CYCS', 'RXRG']",0.6282008624535789,0,0,7
226,TGF-beta Signaling Pathway WP366,0.2973301454458632,1.238470341407591,1.5021557328333395,"['KLF10', 'CDKN1A', 'KLF6', 'SHC1', 'LIMK2', 'TNC', 'FN1', 'NEDD4L', 'JUNB', 'PML', 'MAP2K6']",0.6282008624535789,0,0,11
227,Cell migration and invasion through p75NTR WP4561,0.29901836459168263,1.6536178107606678,1.9963305773542586,"['EFNA1', 'BDNF', 'PARD3']",0.6282008624535789,0,0,3
228,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.29901836459168263,1.6536178107606678,1.9963305773542586,"['P4HA2', 'P3H2', 'TNFRSF11B']",0.6282008624535789,0,0,3
229,Hepatitis B infection WP4666,0.3062310698226979,1.2147166605161301,1.4375143199175733,"['CDKN1A', 'TICAM2', 'EGR3', 'STAT1', 'IRF7', 'NFATC2', 'CYCS', 'FAS', 'NFATC1', 'TAB2', 'MYD88', 'MAP2K6']",0.6405444648256432,0,0,12
230,DNA Replication WP466,0.3129486669925265,1.4700092850510678,1.707733461106161,"['POLD4', 'PRIM1', 'RPA3', 'CDC7']",0.6517496151713922,0,0,4
231,PPAR signaling pathway WP3942,0.31929130398407835,1.3782527881040891,1.5734842447437456,"['FABP5', 'SCD', 'DBI', 'ANGPTL4', 'RXRG']",0.6620802363998854,0,0,5
232,TYROBP causal network in microglia WP3945,0.3225637585381298,1.5747415849456665,1.7817483918280634,"['IL18', 'PPP1R18', 'IL13RA1']",0.6659829324989835,0,0,3
233,Cori Cycle WP1946,0.32735690449370897,1.8368860055607044,2.05125841327773,"['LDHA', 'GPT']",0.6729783573068094,0,0,2
234,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.34611328167644295,1.5030359251138472,1.5947048143478473,"['ACTA2', 'PRKCQ', 'TNFRSF1A']",0.6920418364234531,0,0,3
235,IL-6 signaling pathway WP364,0.35189496719404173,1.3779015784586814,1.4391114617094691,"['SOCS3', 'SHC1', 'STAT1', 'JUNB']",0.6920418364234531,0,0,4
236,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.35242311058463877,1.272128801431127,1.3267321398482765,"['TUBA1C', 'TUBB6', 'TUBB2B', 'RNF19A', 'HSPA1B', 'HSPA1A']",0.6920418364234531,0,0,6
237,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.35252235508835605,2.7546296296296298,2.8720904529163964,['COX8A'],0.6920418364234531,0,0,1
238,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.35252235508835605,2.7546296296296298,2.8720904529163964,['HSD11B1'],0.6920418364234531,0,0,1
239,Osteoblast Signaling WP322,0.35252235508835605,2.7546296296296298,2.8720904529163964,['TNFRSF11B'],0.6920418364234531,0,0,1
240,Robo4 and VEGF Signaling Pathways Crosstalk WP3943,0.35252235508835605,2.7546296296296298,2.8720904529163964,['VEGFA'],0.6920418364234531,0,0,1
241,SARS-CoV-2 and COVID-19 Pathway WP4846,0.35252235508835605,2.7546296296296298,2.8720904529163964,['NRP1'],0.6920418364234531,0,0,1
242,Serotonin Transporter Activity WP1455,0.35252235508835605,2.7546296296296298,2.8720904529163964,['IL1R1'],0.6920418364234531,0,0,1
243,Tgif disruption of Shh signaling WP3674,0.35252235508835605,2.7546296296296298,2.8720904529163964,['TGIF2'],0.6920418364234531,0,0,1
244,Vitamin D Metabolism WP1531,0.35252235508835605,2.7546296296296298,2.8720904529163964,['DHCR7'],0.6920418364234531,0,0,1
245,Constitutive Androstane Receptor Pathway WP2875,0.3587202263122123,1.6954444998930633,1.738190908266808,"['HSP90AA1', 'CYP3A5']",0.6928507596917326,0,0,2
246,ERK Pathway in Huntington's Disease WP3853,0.3587202263122123,1.6954444998930633,1.738190908266808,"['EGF', 'BDNF']",0.6928507596917326,0,0,2
247,MAPK pathway in congenital thyroid cancer WP4928,0.3587202263122123,1.6954444998930633,1.738190908266808,"['GAREM2', 'SHC1']",0.6928507596917326,0,0,2
248,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.3587202263122123,1.6954444998930633,1.738190908266808,"['ACTN1', 'PRKCQ']",0.6928507596917326,0,0,2
249,Integrated breast cancer pathway WP1984,0.3672347821453425,1.1507544637410014,1.152772774415765,"['BARD1', 'SMAD1', 'PLK3', 'ITPKC', 'ANXA1', 'RASGEF1A', 'GADD45A', 'STAT1', 'FAU', 'PML', 'FOSL2', 'VEGFA']",0.7024980372947089,0,0,12
250,Proteasome Degradation WP183,0.3676845857252598,1.2480210618692409,1.2486822788337795,"['H2AFZ', 'NEDD4', 'HLA-B', 'HLA-C', 'HLA-E', 'PSMB9']",0.7024980372947089,0,0,6
251,Oxidation by Cytochrome P450 WP43,0.3695814308940849,1.437565540050012,1.43092999852753,"['CYP39A1', 'CYP4F3', 'CYP3A5']",0.7024980372947089,0,0,3
252,Oxysterols derived from cholesterol WP4545,0.3695814308940849,1.437565540050012,1.43092999852753,"['CYP39A1', 'HSD3B7', 'DHCR7']",0.7024980372947089,0,0,3
253,TGF-beta Receptor Signaling WP560,0.3713986399054714,1.336034439098506,1.3233144455194923,"['SMAD1', 'STAT1', 'EGF', 'SMAD9']",0.7031618518368411,0,0,4
254,Nanomaterial induced apoptosis WP2507,0.38952823877194465,1.574208923606514,1.4841939512947462,"['FAS', 'CYCS']",0.7288438530146933,0,0,2
255,Pregnane X receptor pathway WP2876,0.38952823877194465,1.574208923606514,1.4841939512947462,"['HSP90AA1', 'CYP3A5']",0.7288438530146933,0,0,2
256,Statin inhibition of cholesterol production WP430,0.38952823877194465,1.574208923606514,1.4841939512947462,"['SQLE', 'APOC1']",0.7288438530146933,0,0,2
257,Head and Neck Squamous Cell Carcinoma WP4674,0.3982629179810234,1.2024355179704016,1.1070137149373505,"['CDKN1A', 'NOTCH1', 'RPS6', 'FGFR3', 'NFKB2', 'VEGFA']",0.7346693838175632,0,0,6
258,Kit receptor signaling pathway WP304,0.4041921959954009,1.2245972738537794,1.1093195418854678,"['KITLG', 'SHC1', 'STAT1', 'RPS6', 'JUNB']",0.7346693838175632,0,0,5
259,Aspirin and miRNAs WP4707,0.4064454837404055,2.2035185185185187,1.98383977619065,['VEGFA'],0.7346693838175632,0,0,1
260,Caloric restriction and aging WP4191,0.4064454837404055,2.2035185185185187,1.98383977619065,['NAMPT'],0.7346693838175632,0,0,1
261,Cytokines and Inflammatory Response WP530,0.4064454837404055,2.2035185185185187,1.98383977619065,['HLA-DRB1'],0.7346693838175632,0,0,1
262,Genes targeted by miRNAs in adipocytes WP1992,0.4064454837404055,2.2035185185185187,1.98383977619065,['TMSB4X'],0.7346693838175632,0,0,1
263,HIF1A and PPARG regulation of glycolysis WP2456,0.4064454837404055,2.2035185185185187,1.98383977619065,['LDHA'],0.7346693838175632,0,0,1
264,LDLRAD4 and what we know about it WP4904,0.4064454837404055,2.2035185185185187,1.98383977619065,['NEDD4'],0.7346693838175632,0,0,1
265,"Phase I biotransformations, non P450 WP136",0.4064454837404055,2.2035185185185187,1.98383977619065,['PON1'],0.7346693838175632,0,0,1
266,Alpha 6 Beta 4 signaling pathway WP244,0.41596977579220207,1.3223376623376624,1.1598787953296699,"['SHC1', 'LAMA3', 'IRS2']",0.7417537051114701,0,0,3
267,Gastric Cancer Network 1 WP2361,0.41965606280836826,1.4691380908248377,1.275681695048853,"['NOTCH1', 'GATD3A']",0.7417537051114701,0,0,2
268,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.41965606280836826,1.4691380908248377,1.275681695048853,"['SHC1', 'FLNA']",0.7417537051114701,0,0,2
269,Microglia Pathogen Phagocytosis Pathway WP3937,0.41965606280836826,1.4691380908248377,1.275681695048853,"['C1QB', 'PLCG2']",0.7417537051114701,0,0,2
270,Monoamine Transport WP727,0.41965606280836826,1.4691380908248377,1.275681695048853,"['IL1R1', 'TNFRSF11B']",0.7417537051114701,0,0,2
271,Nucleotide metabolism WP404,0.41965606280836826,1.4691380908248377,1.275681695048853,"['NME2', 'OAZ1']",0.7417537051114701,0,0,2
272,Interleukin-11 Signaling Pathway WP2332,0.4294654749244753,1.2243887341380377,1.034870407868581,"['SOCS3', 'STAT1', 'RPS6', 'ICAM1']",0.7504030372334493,0,0,4
273,Senescence and Autophagy in Cancer WP615,0.43449401187104214,1.1344616058713988,0.9456566958184638,"['CDKN1A', 'CEBPB', 'MAP1LC3A', 'IFI16', 'FN1', 'IRF7', 'CD44']",0.7504030372334493,0,0,7
274,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.44392625519361756,1.139951884522855,0.9257513029400121,"['SREBF1', 'SQLE', 'RBP4', 'SCD', 'FASN', 'DBI']",0.7504030372334493,0,0,6
275,Modulators of TCR signaling and T cell activation WP5072,0.44853304398822064,1.1911967677984392,0.9550693150094168,"['ELOB', 'PRKCQ', 'CD247', 'MAP3K14']",0.7504030372334493,0,0,4
276,Phosphodiesterases in neuronal function WP4222,0.44853304398822064,1.1911967677984392,0.9550693150094168,"['CHRNA7', 'PDE5A', 'ADCY2', 'PDE8B']",0.7504030372334493,0,0,4
277,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.44853304398822064,1.1911967677984392,0.9550693150094168,"['SMAD1', 'STAT1', 'EGF', 'SMAD9']",0.7504030372334493,0,0,4
278,NAD+ biosynthetic pathways WP3645,0.4490034216748217,1.3772011121408712,1.1027590446060054,"['NAMPT', 'CD38']",0.7504030372334493,0,0,2
279,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.4490034216748217,1.3772011121408712,1.1027590446060054,"['NQO1', 'GCLM']",0.7504030372334493,0,0,2
280,AGE/RAGE pathway WP2324,0.45468894852546193,1.1477695167286246,0.9046050450112819,"['LGALS3', 'SHC1', 'STAT1', 'CYCS', 'MYD88']",0.7504030372334493,0,0,5
281,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.45468894852546193,1.1477695167286246,0.9046050450112819,"['CDKN1A', 'NOTCH1', 'PODXL', 'PLCE1', 'MYH9']",0.7504030372334493,0,0,5
282,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.45588159464495565,1.836111111111111,1.4423059734395476,['NFKB2'],0.7504030372334493,0,0,1
283,Biogenic Amine Synthesis WP550,0.45588159464495565,1.836111111111111,1.4423059734395476,['PAH'],0.7504030372334493,0,0,1
284,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.45588159464495565,1.836111111111111,1.4423059734395476,['ID2'],0.7504030372334493,0,0,1
285,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.45588159464495565,1.836111111111111,1.4423059734395476,['CEBPB'],0.7504030372334493,0,0,1
286,Glial Cell Differentiation WP2276,0.45588159464495565,1.836111111111111,1.4423059734395476,['GAP43'],0.7504030372334493,0,0,1
287,Insulin signaling in adipocytes (diabetic condition) WP3635,0.45588159464495565,1.836111111111111,1.4423059734395476,['RPS6'],0.7504030372334493,0,0,1
288,Insulin signaling in adipocytes (normal condition) WP3634,0.45588159464495565,1.836111111111111,1.4423059734395476,['RPS6'],0.7504030372334493,0,0,1
289,Nephrogenesis WP5052,0.45588159464495565,1.836111111111111,1.4423059734395476,['RSPO3'],0.7504030372334493,0,0,1
290,Role of Osx and miRNAs in tooth development WP3971,0.45588159464495565,1.836111111111111,1.4423059734395476,['NOTCH1'],0.7504030372334493,0,0,1
291,Selective expression of chemokine receptors during T-cell polarization WP4494,0.45588159464495565,1.836111111111111,1.4423059734395476,['CXCR4'],0.7504030372334493,0,0,1
292,Pancreatic adenocarcinoma pathway WP4263,0.46224632073551447,1.1018621973929237,0.8502600833763166,"['CDKN1A', 'GADD45B', 'STAT1', 'EGF', 'GADD45A', 'RALGDS', 'VEGFA']",0.7582739302476419,0,0,7
293,Pathogenic Escherichia coli infection WP2272,0.4673941876444201,1.1597517470556615,0.8820866424610855,"['TUBA1C', 'TUBB6', 'TUBB2B', 'ACTG1']",0.762394628251773,0,0,4
294,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.46856039049896814,1.069774187992349,0.8109854177756292,"['SREBF1', 'SHC1', 'SCD', 'RPS6KA2', 'FASN', 'TRIP10', 'IRS2', 'MAP3K6', 'MAP3K14', 'MAP2K6']",0.762394628251773,0,0,10
295,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.4774914164416114,1.2960802485961946,0.9580743079510065,"['BCL6', 'H2AFZ']",0.762394628251773,0,0,2
296,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.4774914164416114,1.2960802485961946,0.9580743079510065,"['BDNF', 'RPS6']",0.762394628251773,0,0,2
297,Genes controlling nephrogenesis WP4823,0.4774914164416114,1.2960802485961946,0.9580743079510065,"['CXCR4', 'VEGFA']",0.762394628251773,0,0,2
298,miRNA regulation of p53 pathway in prostate cancer WP3982,0.4774914164416114,1.2960802485961946,0.9580743079510065,"['TNFRSF10B', 'CYS1']",0.762394628251773,0,0,2
299,Vitamin D in inflammatory diseases WP4482,0.4774914164416114,1.2960802485961946,0.9580743079510065,"['NFATC1', 'MAP2K6']",0.762394628251773,0,0,2
300,Zinc homeostasis WP3529,0.4774914164416114,1.2960802485961946,0.9580743079510065,"['SLC39A11', 'SLC39A14']",0.762394628251773,0,0,2
301,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.48323565249231226,1.18036045587066,0.8584181459620353,"['MAP1LC3A', 'NEB', 'TNFRSF1A']",0.7631658692194978,0,0,3
302,Vitamin D-sensitive calcium signaling in depression WP4698,0.48323565249231226,1.18036045587066,0.8584181459620353,"['CALB1', 'KCNQ3', 'PVALB']",0.7631658692194978,0,0,3
303,G Protein Signaling Pathways WP35,0.4896820753434134,1.0710738671632527,0.7647455889851973,"['AKAP13', 'GNA14', 'AKAP10', 'GNG3', 'PRKCQ', 'ADCY2', 'PDE8B']",0.7631658692194978,0,0,7
304,Biomarkers for urea cycle disorders WP4583,0.5012037410584206,1.5736772486772488,1.0870059013849243,['GPT'],0.7631658692194978,0,0,1
305,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.5012037410584206,1.5736772486772488,1.0870059013849243,['ELOB'],0.7631658692194978,0,0,1
306,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.5012037410584206,1.5736772486772488,1.0870059013849243,['STAT1'],0.7631658692194978,0,0,1
307,LTF danger signal response pathway WP4478,0.5012037410584206,1.5736772486772488,1.0870059013849243,['MYD88'],0.7631658692194978,0,0,1
308,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.5012037410584206,1.5736772486772488,1.0870059013849243,['ANXA2'],0.7631658692194978,0,0,1
309,Osteoclast Signaling WP12,0.5012037410584206,1.5736772486772488,1.0870059013849243,['TNFRSF11B'],0.7631658692194978,0,0,1
310,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.5012037410584206,1.5736772486772488,1.0870059013849243,['ANAPC11'],0.7631658692194978,0,0,1
311,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.5012037410584206,1.5736772486772488,1.0870059013849243,['MYD88'],0.7631658692194978,0,0,1
312,Gastrin signaling pathway WP4659,0.5029693523579464,1.0491279456796698,0.7209880440291747,"['EGR1', 'CDKN1A', 'ANXA2', 'SHC1', 'RPS6', 'PRKCQ', 'CD44', 'VEGFA']",0.7631658692194978,0,0,8
313,IL-5 signaling pathway WP127,0.5048356610798681,1.1395624080353144,0.778916348073275,"['SHC1', 'STAT1', 'RPS6']",0.7631658692194978,0,0,3
314,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.5048356610798681,1.1395624080353144,0.778916348073275,"['STAT1', 'RPS6', 'NFKB2']",0.7631658692194978,0,0,3
315,7-oxo-C and 7beta-HC pathways WP5064,0.505059667103509,1.22397281433426,0.8360697637540713,"['HSD11B1', 'DHCR7']",0.7631658692194978,0,0,2
316,Fatty Acid Biosynthesis WP357,0.505059667103509,1.22397281433426,0.8360697637540713,"['SCD', 'FASN']",0.7631658692194978,0,0,2
317,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.505059667103509,1.22397281433426,0.8360697637540713,"['CEBPB', 'ATP2C2']",0.7631658692194978,0,0,2
318,Insulin Signaling WP481,0.5224876884846723,1.016679858962366,0.6599816529280135,"['SOCS3', 'EGR1', 'SNAP25', 'XBP1', 'SHC1', 'RPS6KA2', 'IRS2', 'PRKCQ', 'MAP3K6', 'MAP3K14', 'MAP2K6', 'ARF6']",0.7845504789472039,0,0,12
319,Ras signaling WP4223,0.5224876884846723,1.016679858962366,0.6599816529280135,"['GNG3', 'MRAS', 'SHC1', 'RASA4', 'PLCG2', 'PLCE1', 'CALM3', 'PLA2G5', 'RALGDS', 'FGFR3', 'EPHA2', 'ARF6']",0.7845504789472039,0,0,12
320,Glycolysis and Gluconeogenesis WP534,0.5259581888093284,1.1014842300556587,0.7077405818145266,"['LDHA', 'PGAM2', 'GCK']",0.784841035637596,0,0,3
321,Phosphoinositides metabolism WP4971,0.5259581888093284,1.1014842300556587,0.7077405818145266,"['PLCG2', 'PIP4K2A', 'PLCE1']",0.784841035637596,0,0,3
322,SARS-CoV-2 mitochondrial interactions WP5038,0.5316637805432635,1.1594556363104238,0.7324791193496122,"['IRF7', 'NFKB2']",0.787815635730962,0,0,2
323,Corticotropin-releasing hormone signaling pathway WP2355,0.5325274954004742,1.0325581395348837,0.6506363074196556,"['HSP90AA1', 'IL18', 'PLCG2', 'PRKCQ', 'JUNB', 'FOSL2']",0.787815635730962,0,0,6
324,15q13.3 copy number variation syndrome WP4942,0.5427539870380323,1.3768518518518518,0.8413929608984421,['CHRNA7'],0.787815635730962,0,0,1
325,Cancer immunotherapy by CTLA4 blockade WP4582,0.5427539870380323,1.3768518518518518,0.8413929608984421,['HLA-DRB1'],0.787815635730962,0,0,1
326,"Degradation pathway of sphingolipids, including diseases WP4153",0.5427539870380323,1.3768518518518518,0.8413929608984421,['NEU4'],0.787815635730962,0,0,1
327,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.5427539870380323,1.3768518518518518,0.8413929608984421,['PRKCQ'],0.787815635730962,0,0,1
328,NLR Proteins WP288,0.5427539870380323,1.3768518518518518,0.8413929608984421,['ERBIN'],0.787815635730962,0,0,1
329,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.5427539870380323,1.3768518518518518,0.8413929608984421,['CCND2'],0.787815635730962,0,0,1
330,Trans-sulfuration pathway WP2333,0.5427539870380323,1.3768518518518518,0.8413929608984421,['GCLM'],0.787815635730962,0,0,1
331,Prader-Willi and Angelman Syndrome WP3998,0.5465720016315677,1.0658627087198516,0.6438761825426587,"['PCSK1', 'CCND2', 'BDNF']",0.7885782794624124,0,0,3
332,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.5465720016315677,1.0658627087198516,0.6438761825426587,"['CCL2', 'MAP3K14', 'NFKB2']",0.7885782794624124,0,0,3
333,Apoptosis WP254,0.5513374593189431,1.0197232548533663,0.6071515962817188,"['IRF7', 'TNFRSF10B', 'FAS', 'CYCS', 'TNFRSF1A']",0.7906905479454304,0,0,5
334,Endometrial cancer WP4155,0.5513374593189431,1.0197232548533663,0.6071515962817188,"['CDKN1A', 'GADD45B', 'EGF', 'GADD45A', 'FGFR3']",0.7906905479454304,0,0,5
335,Pre-implantation embryo WP3527,0.5572731115631778,1.1013901760889713,0.643982652312478,"['EGR1', 'ZFP36']",0.7944458941629827,0,0,2
336,Trans-sulfuration and one-carbon metabolism WP2525,0.5572731115631778,1.1013901760889713,0.643982652312478,"['AHCYL1', 'GCLM']",0.7944458941629827,0,0,2
337,Melanoma WP4685,0.5666433642413323,1.001098344035147,0.5686490474252448,"['GRM3', 'CDKN1A', 'GADD45B', 'GADD45A', 'CALM3']",0.8006663171397476,0,0,5
338,Integrated Cancer Pathway WP1971,0.5666511096249988,1.0324675324675325,0.5864534231307313,"['BARD1', 'CDKN1A', 'STAT1']",0.8006663171397476,0,0,3
339,Nephrotic syndrome WP4758,0.5666511096249988,1.0324675324675325,0.5864534231307313,"['PODXL', 'PLCE1', 'MYH9']",0.8006663171397476,0,0,3
340,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.5808459790511684,1.2237654320987654,0.6648346223496033,['SMAD1'],0.8078699943765638,0,0,1
341,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.5808459790511684,1.2237654320987654,0.6648346223496033,['PRKCQ'],0.8078699943765638,0,0,1
342,Major receptors targeted by epinephrine and norepinephrine WP4589,0.5808459790511684,1.2237654320987654,0.6648346223496033,['ADCY2'],0.8078699943765638,0,0,1
343,Osteopontin Signaling WP1434,0.5808459790511684,1.2237654320987654,0.6648346223496033,['MAP3K14'],0.8078699943765638,0,0,1
344,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.5808459790511684,1.2237654320987654,0.6648346223496033,['SAMHD1'],0.8078699943765638,0,0,1
345,Photodynamic therapy-induced unfolded protein response WP3613,0.5818687850937673,1.0488547596981332,0.5679656679936385,"['XBP1', 'WARS']",0.8078699943765638,0,0,2
346,Copper homeostasis WP3286,0.6051251696083507,0.9715704463603623,0.4880392184606709,"['STEAP3', 'STEAP4', 'ATOX1']",0.8331992631906024,0,0,3
347,16p11.2 distal deletion syndrome WP4950,0.6054419518875155,1.0010952902519168,0.5023462015601763,"['PLN', 'NFATC2']",0.8331992631906024,0,0,2
348,Alanine and aspartate metabolism WP106,0.6157673051554765,1.1012962962962962,0.5340033081092364,['GPT'],0.8331992631906024,0,0,1
349,Biomarkers for pyrimidine metabolism disorders WP4584,0.6157673051554765,1.1012962962962962,0.5340033081092364,['NT5C'],0.8331992631906024,0,0,1
350,Ganglio Sphingolipid Metabolism WP1423,0.6157673051554765,1.1012962962962962,0.5340033081092364,['ST8SIA1'],0.8331992631906024,0,0,1
351,Glycolysis in senescence WP5049,0.6157673051554765,1.1012962962962962,0.5340033081092364,['LDHA'],0.8331992631906024,0,0,1
352,Homologous recombination WP186,0.6157673051554765,1.1012962962962962,0.5340033081092364,['POLD4'],0.8331992631906024,0,0,1
353,"NAD metabolism, sirtuins and aging WP3630",0.6157673051554765,1.1012962962962962,0.5340033081092364,['NAMPT'],0.8331992631906024,0,0,1
354,RalA downstream regulated genes WP2290,0.6157673051554765,1.1012962962962962,0.5340033081092364,['YBX3'],0.8331992631906024,0,0,1
355,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.6250293690288413,0.9329122298531913,0.43842829686678625,"['CDKN1A', 'GADD45B', 'GADD45A', 'CYCS', 'RALGDS']",0.8433494866614507,0,0,5
356,Resistin as a regulator of inflammation WP4481,0.6279922529658535,0.9574888181488496,0.4454500799607352,"['PLCG2', 'PLCE1']",0.8449671044119208,0,0,2
357,Mesodermal commitment pathway WP2857,0.633595237931542,0.9267866777848629,0.42293442421322436,"['SMAD1', 'FZD5', 'FZD4', 'PBX3', 'ARID5B', 'HMGA2', 'RPL38', 'TBX6']",0.8501179803059065,0,0,8
358,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.6412628776365267,0.9174397031539888,0.4076329562224378,"['NFATC2', 'PRKCQ', 'MAP3K14']",0.8533963057549264,0,0,3
359,EGF/EGFR signaling pathway WP437,0.6434583622666349,0.9238995505457659,0.407345426287632,"['PTPRR', 'PLSCR1', 'SHC1', 'STAT1', 'EGF', 'RPS6KA2', 'LIMK2', 'NEDD4', 'PLCE1', 'RALGDS', 'ARF6']",0.8533963057549264,0,0,11
360,Chemokine signaling pathway WP3929,0.6445008959568108,0.9170549860205033,0.40284305813863774,"['GNG3', 'GRK5', 'SHC1', 'STAT1', 'PARD3', 'CXCR4', 'PRKX', 'ADCY2']",0.8533963057549264,0,0,8
361,Cell Differentiation - Index expanded WP2023,0.6477816578358213,1.001094276094276,0.4346767236107111,['ID2'],0.8533963057549264,0,0,1
362,Pyrimidine metabolism and related diseases WP4225,0.6477816578358213,1.001094276094276,0.4346767236107111,['NT5C'],0.8533963057549264,0,0,1
363,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.6495264694226008,0.917516218721038,0.3959189742935589,"['RAB13', 'NDRG1']",0.8533963057549264,0,0,2
364,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.6495264694226008,0.917516218721038,0.3959189742935589,"['LDHA', 'VEGFA']",0.8533963057549264,0,0,2
365,Leptin signaling pathway WP2034,0.6523790853373117,0.9021725882137851,0.3853444965519336,"['SOCS3', 'SHC1', 'STAT1', 'RPS6', 'PLCG2']",0.8533963057549264,0,0,5
366,Acute viral myocarditis WP4298,0.6538547895867599,0.8985655543554469,0.38177353490272176,"['STAT1', 'CXCR4', 'CYCS', 'NFKB2']",0.8533963057549264,0,0,4
367,Regulatory circuits of the STAT3 signaling pathway WP4538,0.6538547895867599,0.8985655543554469,0.38177353490272176,"['GHR', 'IFNAR2', 'SOCS3', 'OSMR']",0.8533963057549264,0,0,4
368,BDNF-TrkB Signaling WP3676,0.6700573383361378,0.8807414272474513,0.35264181330588523,"['SHC1', 'BDNF']",0.8649217650044785,0,0,2
369,Lipid Metabolism Pathway WP3965,0.6700573383361378,0.8807414272474513,0.35264181330588523,"['FASN', 'HILPDA']",0.8649217650044785,0,0,2
370,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.6771308181141532,0.9175925925925926,0.3577609032673415,['CD38'],0.8649217650044785,0,0,1
371,Cysteine and methionine catabolism WP4504,0.6771308181141532,0.9175925925925926,0.3577609032673415,['SQOR'],0.8649217650044785,0,0,1
372,Omega-3/Omega-6 FA synthesis WP4723,0.6771308181141532,0.9175925925925926,0.3577609032673415,['PLA2G5'],0.8649217650044785,0,0,1
373,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.6771308181141532,0.9175925925925926,0.3577609032673415,['LDHA'],0.8649217650044785,0,0,1
374,PPAR-alpha pathway WP2878,0.6771308181141532,0.9175925925925926,0.3577609032673415,['DBI'],0.8649217650044785,0,0,1
375,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.6771308181141532,0.9175925925925926,0.3577609032673415,['F3'],0.8649217650044785,0,0,1
376,Nuclear receptors WP170,0.6896025156955389,0.8467954658872175,0.31470299207623437,"['ESRRB', 'RXRG']",0.875603201838354,0,0,2
377,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.6909770569830852,0.8466533466533467,0.31296427371611907,"['ADCY2', 'EMD', 'SYNE2']",0.875603201838354,0,0,3
378,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.6909770569830852,0.8466533466533467,0.31296427371611907,"['MAP1LC3A', 'CP', 'FTL']",0.875603201838354,0,0,3
379,AMP-activated protein kinase (AMPK) signaling WP1403,0.6963847976286032,0.8465109635026069,0.30631244809865216,"['CCNA2', 'SREBF1', 'CDKN1A', 'FASN']",0.8788082338112548,0,0,4
380,Glioblastoma signaling pathways WP2261,0.7031338395331691,0.8463683156991707,0.2980977102609724,"['CDKN1A', 'CCND2', 'PLCG2', 'PRKCQ', 'MAP2K6']",0.8788082338112548,0,0,5
381,Airway smooth muscle cell contraction WP4962,0.7040364742111405,0.846937321937322,0.2972115764271761,['CD38'],0.8788082338112548,0,0,1
382,IL-9 signaling pathway WP22,0.7040364742111405,0.846937321937322,0.2972115764271761,['STAT1'],0.8788082338112548,0,0,1
383,Monoamine GPCRs WP58,0.7040364742111405,0.846937321937322,0.2972115764271761,['HTR1E'],0.8788082338112548,0,0,1
384,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.7063491199361521,0.825417439703154,0.28695279023539383,"['XBP1', 'MAP1LC3A', 'PPP1R3C']",0.8788082338112548,0,0,3
385,Base Excision Repair WP4752,0.7081836706704475,0.8153640201832973,0.28134282043986975,"['POLE4', 'POLD4']",0.8788082338112548,0,0,2
386,PDGFR-beta pathway WP3972,0.7081836706704475,0.8153640201832973,0.28134282043986975,"['SHC1', 'STAT1']",0.8788082338112548,0,0,2
387,B Cell Receptor Signaling Pathway WP23,0.7149817413897628,0.8334741466711727,0.2796291369083508,"['BCL6', 'SHC1', 'PLCG2', 'NFATC2', 'MAP2K6']",0.884951561048311,0,0,5
388,Nucleotide Excision Repair WP4753,0.7211281679086375,0.8052174306529707,0.26325649311994925,"['POLE4', 'POLD4', 'RPA3']",0.8902587433717458,0,0,3
389,ATM Signaling Pathway WP2516,0.7258256961990595,0.7861776777439428,0.25192700537075147,"['CDKN1A', 'GADD45A']",0.8937545205124666,0,0,2
390,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.7287018905067855,0.7863756613756614,0.24888047340286876,['MAP2K6'],0.8949953988532058,0,0,1
391,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.7425560231128099,0.7590041865073024,0.22592287813625675,"['NFATC2', 'NFATC1']",0.909678606319785,0,0,2
392,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.751313436828859,0.7338888888888889,0.20984257830496583,['PLA2G5'],0.9110864208633506,0,0,1
393,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.751313436828859,0.7338888888888889,0.20984257830496583,['BCL2L14'],0.9110864208633506,0,0,1
394,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.751313436828859,0.7338888888888889,0.20984257830496583,['EGR1'],0.9110864208633506,0,0,1
395,Triacylglyceride synthesis WP325,0.751313436828859,0.7338888888888889,0.20984257830496583,['MOGAT1'],0.9110864208633506,0,0,1
396,Amyotrophic lateral sclerosis (ALS) WP2447,0.7584040259716501,0.7336422613531047,0.2028807116539264,"['MAP2K6', 'TNFRSF1A']",0.9127525840211568,0,0,2
397,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.7584040259716501,0.7336422613531047,0.2028807116539264,"['SHC1', 'BDNF']",0.9127525840211568,0,0,2
398,NO/cGMP/PKG mediated Neuroprotection WP4008,0.7584040259716501,0.7336422613531047,0.2028807116539264,"['ACTN2', 'CYCS']",0.9127525840211568,0,0,2
399,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.7619858530464638,0.7501264968797436,0.20390485207163161,"['DDX3Y', 'RNF125', 'IRF7']",0.9147649714517698,0,0,3
400,Regulation of Actin Cytoskeleton WP51,0.7762834551146431,0.7993899855968821,0.2024355600775788,"['MRAS', 'EGF', 'ACTN1', 'TMSB4X', 'FN1', 'PIP4K2A', 'FGFR3', 'ACTG1']",0.9295994374997851,0,0,8
401,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.7910442298249891,0.6474400871459695,0.15176086053674934,['SREBF1'],0.9309832581969772,0,0,1
402,Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex WP3657,0.7910442298249891,0.6474400871459695,0.15176086053674934,['ETV6'],0.9309832581969772,0,0,1
403,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.7910442298249891,0.6474400871459695,0.15176086053674934,['MAP1LC3A'],0.9309832581969772,0,0,1
404,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.7910442298249891,0.6474400871459695,0.15176086053674934,['MRAS'],0.9309832581969772,0,0,1
405,One-carbon metabolism WP241,0.7910442298249891,0.6474400871459695,0.15176086053674934,['GLRX'],0.9309832581969772,0,0,1
406,Purinergic signaling WP4900,0.7910442298249891,0.6474400871459695,0.15176086053674934,['P2RY14'],0.9309832581969772,0,0,1
407,Urea cycle and associated pathways WP4595,0.7910442298249891,0.6474400871459695,0.15176086053674934,['GPT'],0.9309832581969772,0,0,1
408,Oxidative phosphorylation WP623,0.797849467471937,0.7020684482690561,0.15855186431688933,"['NDUFA7', 'NDUFA4', 'NDUFB2']",0.93357712230049,0,0,3
409,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.8009667125300058,0.6667790041284017,0.1479821918266123,"['ACTA2', 'ACTG1']",0.93357712230049,0,0,2
410,Male infertility WP4673,0.8065628127419981,0.7328996282527881,0.15755399920347274,"['NQO1', 'PON1', 'FAS', 'TEX15', 'SOD2']",0.93357712230049,0,0,5
411,Hippo-Yap signaling pathway WP4537,0.8084637993377588,0.6114197530864197,0.12999968641190465,['NDRG1'],0.93357712230049,0,0,1
412,Kallmann's Syndrome WP5074,0.8084637993377588,0.6114197530864197,0.12999968641190465,['PRKCQ'],0.93357712230049,0,0,1
413,PKC-gamma calcium signaling pathway in ataxia WP4760,0.8084637993377588,0.6114197530864197,0.12999968641190465,['GNA14'],0.93357712230049,0,0,1
414,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.8084637993377588,0.6114197530864197,0.12999968641190465,['NFATC2'],0.93357712230049,0,0,1
415,DNA IR-damage and cellular response via ATR WP4016,0.8105771584161926,0.7093779015784587,0.1489755619886163,"['BARD1', 'SEM1', 'BCL6', 'PML']",0.93357712230049,0,0,4
416,Hedgehog Signaling Pathway WP4249,0.8136015333978099,0.6471133402387832,0.13348948389398577,"['EVC2', 'CCND2']",0.93357712230049,0,0,2
417,PDGF Pathway WP2526,0.8136015333978099,0.6471133402387832,0.13348948389398577,"['SHC1', 'STAT1']",0.93357712230049,0,0,2
418,22q11.2 copy number variation syndrome WP4657,0.8151223551556438,0.7231950694580317,0.14783340121532404,"['ACTA2', 'SREBF1', 'AIFM3', 'THAP7', 'HES1']",0.93357712230049,0,0,5
419,ErbB signaling pathway WP673,0.8233757335456483,0.7137425771254767,0.1387106175188111,"['CDKN1A', 'SHC1', 'EGF', 'PLCG2', 'NRG1']",0.93357712230049,0,0,5
420,Glycerolipids and Glycerophospholipids WP4722,0.8244324065409337,0.5791910331384016,0.11181869122605256,['PNPLA3'],0.93357712230049,0,0,1
421,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.8244324065409337,0.5791910331384016,0.11181869122605256,['CCND2'],0.93357712230049,0,0,1
422,IL-7 signaling pathway WP205,0.8244324065409337,0.5791910331384016,0.11181869122605256,['STAT1'],0.93357712230049,0,0,1
423,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.8244324065409337,0.5791910331384016,0.11181869122605256,['NAMPT'],0.93357712230049,0,0,1
424,Alzheimer's disease WP2059,0.8286190629373608,0.6870937790157846,0.129170018680162,"['FAS', 'CYCS', 'CALM3', 'TNFRSF1A']",0.9361050262900845,0,0,4
425,IL-3 signaling pathway WP286,0.8367379525240276,0.6110596231078159,0.10891791734797233,"['SHC1', 'ENPP3']",0.9368646066454585,0,0,2
426,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.837091132799388,0.6764659667166631,0.12029075716355518,"['EGF', 'NRG1', 'MAP3K14', 'MAP2K6']",0.9368646066454585,0,0,4
427,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.8390708063693145,0.5501851851851852,0.09653559289702582,['HGF'],0.9368646066454585,0,0,1
428,Nanoparticle triggered autophagic cell death WP2509,0.8390708063693145,0.5501851851851852,0.09653559289702582,['MAP1LC3A'],0.9368646066454585,0,0,1
429,Sphingolipid Metabolism (general overview) WP4725,0.8390708063693145,0.5501851851851852,0.09653559289702582,['UGCG'],0.9368646066454585,0,0,1
430,Amino Acid metabolism WP3925,0.8452097414826109,0.6661602093356968,0.11202847393569303,"['LDHA', 'WARS', 'P4HA2', 'GCLM']",0.9375542049903944,0,0,4
431,Metabolic reprogramming in colon cancer WP4290,0.8473041503545965,0.5944944017233174,0.0985050813005145,"['LDHA', 'FASN']",0.9375542049903944,0,0,2
432,Netrin-UNC5B signaling pathway WP4747,0.8473041503545965,0.5944944017233174,0.0985050813005145,"['CCL2', 'ICAM1']",0.9375542049903944,0,0,2
433,MET in type 1 papillary renal cell carcinoma WP4205,0.8475176842606279,0.6342942771514201,0.10493991190122862,"['CDKN1A', 'HGF', 'RPL11']",0.9375542049903944,0,0,3
434,Sphingolipid Metabolism (integrated pathway) WP4726,0.852489712722319,0.5239417989417989,0.08361803928496798,['UGCG'],0.9408815032119603,0,0,1
435,Pathways affected in adenoid cystic carcinoma WP3651,0.8560723579568644,0.6222739524626317,0.0967016062433563,"['NOTCH1', 'ERBIN', 'ARID5B']",0.9426635849685933,0,0,3
436,Endothelin Pathways WP2197,0.8647906325388282,0.5000841750841751,0.0726461502606417,['EDNRA'],0.9444378161037931,0,0,1
437,Gastric Cancer Network 2 WP2363,0.8647906325388282,0.5000841750841751,0.0726461502606417,['S100A6'],0.9444378161037931,0,0,1
438,MTHFR deficiency WP4288,0.8647906325388282,0.5000841750841751,0.0726461502606417,['CYCS'],0.9444378161037931,0,0,1
439,Pathways in clear cell renal cell carcinoma WP4018,0.8675420440201858,0.6370352428242703,0.09051716745897503,"['LDHA', 'FASN', 'ENPP3', 'VEGFA']",0.9444378161037931,0,0,4
440,Pathways Regulating Hippo Signaling WP4540,0.8675420440201858,0.6370352428242703,0.09051716745897503,"['CDH4', 'PRKCQ', 'FGFR3', 'EPHA2']",0.9444378161037931,0,0,4
441,Eukaryotic Transcription Initiation WP405,0.8753707062564436,0.5497683039851714,0.07317845937751631,"['POLR2I', 'POLR2K']",0.9494025251233096,0,0,2
442,Sphingolipid pathway WP1422,0.8760666306983358,0.4783011272141707,0.06328551850550339,['UGCG'],0.9494025251233096,0,0,1
443,Synaptic Vesicle Pathway WP2267,0.8913531153599796,0.5235005957897524,0.060210220255717,"['SNAP25', 'RIMS1']",0.9621650050502674,0,0,2
444,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.8958780631574513,0.43996296296296294,0.04837435255954611,['PRKCQ'],0.9621650050502674,0,0,1
445,Nanoparticle-mediated activation of receptor signaling WP2643,0.8958780631574513,0.43996296296296294,0.04837435255954611,['FN1'],0.9621650050502674,0,0,1
446,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.8958780631574513,0.43996296296296294,0.04837435255954611,['CALM3'],0.9621650050502674,0,0,1
447,Hippo-Merlin Signaling Dysregulation WP4541,0.9091264010832208,0.5780188633142745,0.055068515688117846,"['CDH4', 'FGFR3', 'CD44', 'EPHA2']",0.9742092754336975,0,0,4
448,Rett syndrome causing genes WP4312,0.9177581923793677,0.4778176250151106,0.04100694410180842,"['HAP1', 'SYNE2']",0.9769293166240945,0,0,2
449,Development of ureteric collection system WP5053,0.9198228012473209,0.3927248677248677,0.032821680318856274,['SMAD1'],0.9769293166240945,0,0,1
450,miRNA regulation of prostate cancer signaling pathways WP3981,0.9198228012473209,0.3927248677248677,0.032821680318856274,['CDKN1A'],0.9769293166240945,0,0,1
451,Proximal tubule transport WP4917,0.9198228012473209,0.3927248677248677,0.032821680318856274,['SLC22A6'],0.9769293166240945,0,0,1
452,Translation Factors WP107,0.9233466424886367,0.4676118549484353,0.037292304641138044,"['EIF4A2', 'EEF1B2']",0.978502304761188,0,0,2
453,Neural Crest Cell Migration during Development WP4564,0.9265123262918857,0.3791507024265645,0.028939787970397705,['BDNF'],0.9791967237674548,0,0,1
454,Mitochondrial complex I assembly model OXPHOS system WP4324,0.9285756696364131,0.4578313253012048,0.03392686005794187,"['NDUFA7', 'NDUFB2']",0.9791967237674548,0,0,2
455,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.9301346749774362,0.506878835450264,0.036711151547751675,"['NOTCH1', 'RPS6', 'PRKCQ']",0.9791967237674548,0,0,3
456,Signaling of Hepatocyte Growth Factor Receptor WP313,0.9382647931468703,0.35462962962962963,0.022598090254904512,['HGF'],0.9843989517360482,0,0,1
457,MAPK Cascade WP422,0.9434167725947272,0.3435185185185185,0.02000896760312793,['MAP2K6'],0.9843989517360482,0,0,1
458,Neural Crest Cell Migration in Cancer WP4565,0.9434167725947272,0.3435185185185185,0.02000896760312793,['BDNF'],0.9843989517360482,0,0,1
459,Parkinson's disease pathway WP2371,0.9434167725947272,0.3435185185185185,0.02000896760312793,['CYCS'],0.9843989517360482,0,0,1
460,7q11.23 copy number variation syndrome WP4932,0.9453518116880629,0.5164236168004807,0.029022043240519945,"['SNAP25', 'FZD9', 'FAS', 'NRG1']",0.9843989517360482,0,0,4
461,Thermogenesis WP4321,0.9513516924780944,0.5044664297377773,0.025158483157994713,"['RPS6KA2', 'RPS6', 'ADCY2', 'ACTG1']",0.9875152388310615,0,0,4
462,G13 Signaling Pathway WP524,0.9524677251355959,0.3232570806100218,0.01574231497082783,['PIP4K2A'],0.9875152388310615,0,0,1
463,Common Pathways Underlying Drug Addiction WP2636,0.9600719647032393,0.3052469135802469,0.012437906395755066,['ACTG1'],0.9920427117364008,0,0,1
464,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.9629918155394507,0.5345887691435054,0.020159538219128848,"['EGR1', 'SHC1', 'BDNF', 'STAT1', 'RPS6', 'IRS2']",0.9920427117364008,0,0,6
465,Androgen receptor signaling pathway WP138,0.9653935993245856,0.43311200078117373,0.015253938673410138,"['CDKN1A', 'LIMK2', 'FLNA']",0.9920427117364008,0,0,3
466,Integrin-mediated Cell Adhesion WP185,0.9653935993245856,0.43311200078117373,0.015253938673410138,"['CAV3', 'SHC1', 'MAP2K6']",0.9920427117364008,0,0,3
467,Endoderm differentiation WP2853,0.9678916783028845,0.46662320472549834,0.015228295203679975,"['NOTCH1', 'STAT1', 'PBX3', 'NME1']",0.9920427117364008,0,0,4
468,ATM Signaling Network in Development and Disease  WP3878,0.9692609375629135,0.2816951566951567,0.008794922216468952,['HSPB1'],0.9920427117364008,0,0,1
469,16p11.2 proximal deletion syndrome WP4949,0.9776744666347259,0.34291010194624655,0.007742402786323016,"['TBX6', 'MAP2K6']",0.9970465250639449,0,0,2
470,Wnt Signaling Pathway WP363,0.9783128742798624,0.25540482342807924,0.005599941734345806,['NFATC2'],0.9970465250639449,0,0,1
471,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.981784479987253,0.24401234567901234,0.004485792464246422,['BDNF'],0.9984602248702638,0,0,1
472,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.9909363969808183,0.20704053109713488,0.0018850889955529962,['FN1'],0.9999738470124507,0,0,1
473,3q29 copy number variation syndrome WP4906,0.9916938799721767,0.20318930041152264,0.0016947629542310306,['SLC51A'],0.9999738470124507,0,0,1
474,DNA Repair Pathways Full Network WP4946,0.9958535166998493,0.3068246839942434,0.0012748884104356354,"['POLE4', 'POLD4', 'RPA3']",0.9999738470124507,0,0,3
475,Joubert Syndrome WP4656,0.9977576372845707,0.15881642512077296,0.00035652390780451366,['FLNA'],0.9999738470124507,0,0,1
476,Ciliopathies WP4803,0.99928534939469,0.2871524214435811,0.00020528701478579584,"['EVC2', 'DNAH11', 'SPAG1', 'CCDC65']",0.9999738470124507,0,0,4
477,Fragile X Syndrome  WP4549,0.9994942560933311,0.19341081138714147,9.78410826946188e-05,"['SHC1', 'BDNF']",0.9999738470124507,0,0,2
478,Genes related to primary cilium development (based on CRISPR) WP4536,0.9998348005458142,0.11040965207631874,1.824112101295809e-05,['EVC2'],0.9999738470124507,0,0,1
479,Ciliary landscape WP4352,0.9999738470124507,0.21734447539461468,5.6842816896952556e-06,"['WHRN', 'CDH23', 'USH1C', 'MAPRE2']",0.9999738470124507,0,0,4
